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A B S T R A C T
Most mammalian genes have multiple isoforms which are generated
through the use of alternative transcription initiation sites, termina-
tion sites and internal exons. High-throughput sequencing technolo-
gies enabled the discovery and quantification of many novel RNA
species including protein-coding RNAs, microRNAs, long non-coding
RNAs and others. Currently, what is sequenced is mostly short reads,
not full-length transcripts. Thus, computational methods are needed
to reconstruct transcripts and infer their expression levels from the
RNA-seq data, which is challenging, due to the many biases that are
introduced during sample preparation. The main aim of my thesis
was to improve approaches to isoform reconstruction and quantifica-
tion. I have started by evaluating the performance of isoform quan-
tification methods using two complementary test data sets. The first
was generated by simulating short read sampling from in silico tran-
scriptomes with known transcript abundances and second by prepar-
ing and sequencing in parallel both RNA-seq and 3’end sequencing
reads from the same population of cells. Many of the benchmarked
methods performed comparably well, while a few were outstanding.
However, all methods produced more accurate results of gene-level
estimates than commonly used count-based methods. I have set up
a complementary web service that developers of isoform quantifica-
tion methods can use to compare the accuracy of their approach with
those that we have already surveyed. Transcript quantification meth-
ods generally start from annotated transcripts, whose abundance is
then estimated. However many isoforms are still to be identified.
Currently available RNA-seq-based transcript reconstruction meth-
ods are insufficiently accurate, especially in the identification of tran-
script 5’ or 3’ ends. A catalog of poly(A) sites in the human and
mouse genomes that our group constructed contains thousands of
poly(A) sites located in regions that are currently annotated as in-
tergenic and intronic. They indicate that many transcripts are yet to
be annotated. Towards this goal, we developed the Terminal Exon
Characterization (TEC) tool, which uses annotated intronic poly(A)
sites together with RNA-seq data to reconstruct terminal exons and
associated transcript isoforms. Applying TECtool to various datasets,
we identified many novel tissue-specific transcripts, particularly from
testis and bone marrow. Single cell data indicate that the relatively
low expression of these transcripts is not due to their being expressed
at low levels in individual cells, but rather to their being expressed
in smaller subpopulations of cells. Ribosome profiling data suggest
that novel transcript isoforms lead to the production of new proteins.
TECtool can enrich the existing transcript annotation and support an
improved transcript isoform abundance estimation. These in turn are
relevant for the identification of binding sites for various regulators
(miRNAs, RBPs), and for the annotation of protein domains. Besides
v
developing novel tools, I have put much effort into their automation,
in line with current efforts towards reproducibility of data analysis.
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I N T R O D U C T I O N
The initial assembly of the human genome in the early 2000s [1] [2]
paved the way for great advancements in both molecular and com-
putational biology. A plethora of technologies and experimental de-
signs emerged that enabled researchers to identify the sequence of
thousands of organisms, discover new genes and proteins [3] and
characterize single nucleotide polymorphisms (SNPs) or mutations
[4]. Various Next Generation Sequencing (NGS) platforms [5] have
not only been used in research, but also in clinical settings [6].
One of the fields that emerged from the progress in NGS is that
of transcriptomics, which aims to describe the expression levels, the
localization and the interactions of RNAs. The principal method in
the field is RNA sequencing (RNA-seq) [7], which enables the cap-
ture and quantification of long RNAs such as mRNAs and lincRNAs,
typically from populations of cells. Interestingly, taking advantage of
by-products of endogenous enzymes, it has been found that RNA-
seq can uncover RNA-RNA interactions [8] or gene fusions [9]. Spe-
cific protocols can be used to similarly characterize small non-coding
RNAs such as miRNAs or snoRNAs. Yet other methods have been
developed to map the sites of interaction of RNA Binding Proteins
(RBPs) and miRNAs with their targets. These latter methods start
with the freezing of in vivo interactions by ultraviolet light-mediated
crosslinking, which is followed by the antibody-mediated immuno-
precipitation the protein (with bound RNAs), hence the name of these
methods (CLIP for crosslinking and immunoprecipitation) [10] [11]
[12]. Much of the gene expression analysis can be carried out based
only on sequencing of mRNA 5’ or 3’ ends. Cap Analysis Gene Ex-
pression (CAGE) [13] is used for identification and quantification
of transcription start sites, whereas 3’ end sequencing [14] [15] [16]
[17] is used to identify and quantify terminal exon usage. Finally,
high throughput methods like ribosome profiling [18] are available to
study the translation of mRNAs.
The exponential growth [19] of heterogeneous transcriptomic se-
quencing data has created new demands to store, annotate, distribute
and process these datasets. Public repositories for raw (for example
SRA [20]) or processed (for example GEO [21]) have become impor-
tant resources, to which the entire scientific community contributes.
Specialized databases, providing detailed information about individ-
ual classes of RNAs like miRNAs [22] or snoRNAs [23] have also
been developed, while meta-databases such as RNAcentral [24] com-
bine and trying to improve the consistency of information generated
elsewhere. One of the largest efforts to create a comprehensive cata-
log of transcripts and genes in different organisms is ENSEMBL [25],
with the related GENCODE project [26], which aims to provide a
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high-quality annotation of genes and transcripts for the human and
mouse genome.
Given the tremendous growth of data, the demand for computa-
tional frameworks that enable researchers to handle datasets in an au-
tomated and reproducible way has also increased dramatically. Gen-
eral web-based platforms such as the Galaxy server [27] for biomedi-
cal research have gained many users. Our group developed and main-
tained the clipz web server [28], which enabled the automated, uni-
form analysis of data generated with a variety of different protocols
such as small RNA-seq, mRNA-seq, 3’ end sequencing or crosslinking
and immunoprecipitation (CLIP) of RNA-binding proteins. Command-
line frameworks like Anduril [29], Snakemake [30] or specification
languages like CWL [31] contribute to the effort of reproducible and
open science [32].
1.1 computational analysis of high-throughput sequenc-
ing (hts) data
Various best practices have been proposed for the analysis of HTS
data [33]. Although as mentioned above, a variety of distinct proto-
cols, developed for specific classes of RNAs, are available (for small
RNA-seq, RNA-seq, 3’ end-seq, CLIP, etc.) some of the data analysis
steps are relatively similar.
1.1.1 Preprocessing
Very frequently, samples are pooled (multiplexed) before sequencing
to minimize the cost. To distinguish the samples, unique sequence
identifiers are used when preparing individual libraries. These iden-
tifiers are used to separate (demultiplex) the samples again after se-
quencing. The results of the sequencing run are provided as FASTQ-
formatted [34] files (Figure 1.1 A), generally one file per sample. Many
statistics are calculated on the basis of these FASTQ files (Figure 1.1
A), such as the per base/read quality scores, per base/read G/C con-
tent, overrepresented or duplicated sequences. Tools like FASTQC
[35] have been built to carry out these analyses. The initial statistics
help identify low-quality reads or regions, that should be discarded
or trimmed. Some methods such as TagDust2 [36] select ’mappable’
part of each read. In TagDust2 this is done based on a user-provided
Hidden Markov Model (HMM) [37] that describes the architecture
of the reads and allows the recognition of primer dimers, barcode
sequences, 5’ or 3’ adapters. Other tools like cutadapt [38] are also
used to trim adapters (Figure 1.1 A) and perform quality filtering
steps (Figure 1.1 A). When possible, PCR duplicates are removed. To
avoid repeating the same operations unnecessarily many time, iden-
tical reads are generally collapsed using tools such as those from the
Fastx-Toolkit [39] package. For downstream analyses, important infor-
mation that needs to be extracted is the orientation of the reads, the
average and standard deviation of the length of the fragments pre-
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pared for sequencing. Finally, in many cases, it is helpful to convert
the paired-end reads to single-end, and many methods like FLASH
[40] are built to convert them efficiently.
1.1.2 Alignment methods
After the above-mentioned preprocessing steps have been completed,
reads are mapped to reference sequences (Figure 1.1 A), which in
most cases are the assembled genome of the studied species or the
corresponding transcriptome. To ensure that efficient search, NGS
alignment algorithms [41] follow a two-step procedure. In the first
step a data structure like a hash table [42], a suffix tree [43] or a suffix
array [44] is used to create an index of the reference sequences. In
the second step, the actual mapping between reads and originating
sequences is made. Outputs are currently written out in Sequence
Alignment Map (SAM) [45] format or a compressed version of it
like the Binary Alignment Map (BAM) [45] or the CRAM [46] format.
Alignment files are written out either in ‘random’ order, or sorted by
the name of the read or the coordinates of the read mapping in the
reference sequence. For fastest lookup at later stages, the binary align-
ments should be indexed, and tools like samtools [45], BamTools [47],
or Scramble [48] are built for sorting, indexing or performing other
filtering tasks on alignment files. The nature of the genome and gene
structure of the species of interest informs the downstream analysis
of the alignments. For example, genomes have some degree of repet-
itiveness, as genes and genomic regions undergo duplication during
evolution and therefore some reads map equally well to one or mul-
tiple loci. The multi-mapper rate depends also on the length of the
sequenced reads, as short reads are more likely to match multiple ge-
nomic loci. Many studies ignore multi-mapping reads, although this
leads, of course to mis-estimation of expression, as different genes
have different repeat content and thereby arbitrary fractions of reads
discarded. In some cases, such as for example for multi-copy small
RNAs, discarding the multi-mapping reads would lead to entirely er-
roneous inferences of lack of expression of the multi-copy small RNA.
An issue that has been challenging for a long time was that eukary-
otic genes have introns, and thus reads that straddle splice junctions
are at best difficult to map. Initially, strategies to handle this problem
included generation of exon-exon junction databases to be added to
the genome database for contiguous mapping, or hierarchical map-
ping to transcriptome and genome, both contiguously. The first fast
short read aligners like bowtie [49] mapped the reads only contigu-
ously, whereas second- and third-generation aligners like Tophat [50]
or STAR [51] specialize in gapped alignments. Other aligners like
segemehl [52] [53] are built for both purposes. Many of the spliced
aligners can identify novel splice junctions, enriching the set of anno-
tated junctions. Finally, more recently, the idea of pseudo-alignment
was introduced [54] where for each read a list of compatible tran-
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Figure 1.1: Analysis of HTS data. (A) Overview of the processing steps.
Reads in FASTA or FASTQ format are preprocessed to generate statistics for
data quality statistics, filter low-quality reads and trim adapters. Reads are
then mapped to the genome (green) using an aligner that can handle spliced
reads, or to the transcriptome (blue) with an aligner that only provides un-
spliced mappings. Genomic alignments are in general sorted by coordinates
and indexed, while transcriptomic alignments are sorted by read name. Ge-
nomic or transcriptomic alignments are used to estimate the gene abun-
dance using count-based methods given an annotation file (red). The same
alignments are used as input for methods that estimate transcript abun-
dance. Spliced alignments to the genome are used in methods that identify
novel transcript isoforms. (B) Common splicing events: Skipped Exon (SE),
Mutually Exclusive Exons (MX), Retained Introns (RI), Alternative 5’ Splice
Site (A5), Alternative 3’ Splice Site (A3). Gray boxes indicate exons, lines and
dashed lines indicate different transcript products. (C) Other RNA process-
ing events. Same as in B, but showing Alternative First (AF) and Alternative
Last (AL) Exons. (D) Reads considered for the calculation of the PSI score in
count based methods. Light gray and dark gray boxes indicate exons, lines
joining exons indicate introns. Red boxes are reads indicating the inclusion
of the exon in the middle (dark gray), while blue reads indicate the exclusion
of the read. Dashed lines indicate split reads between exons. White boxes
correspond to reads that are not informative for whether the reference exon
(dark gray) is included or not in a transcript.
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scripts from which the read could originate is reported. This is done
based on the word composition of the read and transcripts.
1.1.3 Quantification methods
One of the main uses of RNA-seq is estimating the expression of
genes or transcripts (Figure 1.1 A). A naive way to infer the expres-
sion level of a gene from a genomic alignments of RNA-seq reads
is to count reads that map to the union of exonic positions in the
locus of that gene. That means that overlapping exons of a gene
are merged into pseudo-exons and reads that overlap with these
pseudo-exons will be counted towards the expression of gene. Typ-
ically, only uniquely mapping reads are used in this analysis. This
crude approach has several disadvantages, which include that reads
crossing real splice junctions are not considered and that the estimate
of expression will be erroneous when the gene has multiple isoforms
expressed at different levels. Other approaches consider known iso-
forms of genes and attempt to quantify their relative expression. Af-
ter estimating the transcripts counts, the estimates are then aggre-
gated at the gene level. In this analysis multi-mapping reads should
be included. Many packages for counting reads have been developed
over time, including HTSeq [55], featureCounts [56], bedtools [57]
and QuasR [58]. They differ in the choice of programming language
(python, R, bash) and in various choices they make for example in
the treatment of multi-mappers. Their accuracy in quantifying expres-
sion is not entirely trivial to analyze as gold standard data sets are
rare. This topic will be addressed also in chapter 2. Rounded counts
per transcript/gene are generally used to infer differential expression
across different conditions (e.g. health and disease), with the general
assumption that the read counts associated with a transcript/gene
follow the negative binomial distribution. The most used packages
for differential expression analysis are edgeR [59] and DESeq [60].
For other analyses, measures such as Reads Per Kilobase per Million
(RPKM) [61] or Transcripts Per Million (TPM) [62] are calculated.
The methods above were mainly developed to estimate gene expres-
sion levels. However, the throughput of sequencing methods became
sufficiently high in recent years to allow one to investigate isoform
expression, which can have strong impact on the cell. Moreover for
recently discovered molecules such as lncRNAs, the annotation may
be highly incomplete and thus the deep sequencing data can also
serve to improve the annotation of gene structures. Different compu-
tational approaches have been designed for estimate relative abun-
dance at transcript level. They take as input spliced alignments to
the genome or contiguous alignments to transcripts. A challenge that
these methods need to address is handling reads that map to multiple
transcripts, that can either come from the same locus, or from differ-
ent loci. Most methods use the Expectation Maximization (EM) ap-
proach [63]. During the Expectation (E) step reads are proportionally
assigned to transcripts according to the isoform abundance, whereas
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during the Maximization step (M) the transcript isoform abundances
are recalculated from the previously assigned read counts [64] [65].
Additional characteristics such as the availability of paired end data
[64] or of information about positional or sequencing biases [64] are
also incorporated in the inference. Although the models underlying
the different methods are generally similar, small differences in pa-
rameters or even in the implementation of the algorithm can lead
to different results. Evaluating the performance of these methods is
not an easy task, especially in the absence of ’ground truth’ isoform
abundance. All methods rely to some extent on simulated data, which
likely lacks biases introduced by difficult to control experimental fac-
tors. In chapter 2 we evaluated the performance of some the most
widely used methods using simulated and real human and mouse
datasets.
1.1.4 Transcript identification methods
The above sections describe analyses that are done with RNA-seq
data assuming that the set of expressed transcripts is known. How-
ever, one of the main applications of RNA-seq is the identification
of novel transcripts/isoforms [66] [67]. There are two types of tools
that try to solve this problem, one using only alignments of reads
to genome and building chains of exons, the other using both ge-
nomic alignments as well as available transcript annotation, to gener-
ate an enriched annotation. The first approach is used for organisms
where the genomic sequence was recently determined and thereby
the gene annotation is very limited, whereas the second approach
is more common for well-studied organisms like human or mouse,
where the interest is frequently in identifying novel transcripts that
have been missed so far, probably because of their highly specific ex-
pression. Although different tools are available [66] [67] they share the
same main principle [65]. Namely, alternative transcript structures are
modeled with a splice graph, different isoforms corresponding to dif-
ferent paths through the graph [68]. The nodes of the graph represent
exons whereas directed arrows represent splicing events. All possible
traversals of the graph, corresponding to potential transcripts, can
be enumerated, using for example a breadth-first-search (BFS) algo-
rithm. Expectation-maximization (EM) is then used to estimate the
relative transcript abundance. While the available transcript recon-
struction methods can identify reasonably well internal exons, which
are supported by spliced reads at both ends, they have relatively poor
performance in identifying the transcript ends, that are not as sharply
defined as the splice junctions and have a poorer coverage due to the
loss of short reads generated from the ends during the fragmentation
step of RNA-seq sample preparation. In one of my projects I have
co-developed a new method (chapter 3) for improved identification
of novel terminal exon isoforms.
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1.1.5 Analysis of alternative splicing isoforms
Splicing [69] [70] [71] is the process where pre-mRNAs are converted
to mature mRNAs by the removal of ‘intronic’ sequences. This pro-
cess takes place co- or post-transcriptionally [72], exons being joined
together to form the mature transcripts, while the introns are de-
graded through specific mechanism or further processed to generate
other functional molecules such as small nucleolar RNAs or microR-
NAs [73]. In higher eukaryotes, many exons are not constitutively
spliced into the transcript, but rather their inclusion or exclusion de-
pends on the binding of splicing factors in regions around the splice
sites. This leads to ‘alternative splicing’ (AS) and to the production
of different transcript isoforms for individual genes, in different cell
types or conditions. Virtually all (more than 95%) of multi-exon hu-
man genes give rise to alternatively spliced isoforms [74].
There are again various approaches to quantify alternative splic-
ing (AS) events or isoforms computationally [75], two being most
common. The first approach is exon-centric: expression of each exon
of a gene is quantified across multiple samples, and the level of in-
clusion/exclusion of a given exon is determined relative to the aver-
age over other exons of that gene. The second approach is transcript
based: one attempts to quantify the expression levels of alternative
isoforms, deriving from these inclusion rates of individual exons. A
generally adopted measure of exon usage is the Percent Splice In (PSI)
score [76] which indicates what fraction of the transcripts of a gene
contain a specific exon, from among all the transcripts that cover the
genomic locus of that exon. This measure is generalized to various
splicing events (Figure 1.1 B and 1.1 C) such as exon skipping (SE),
mutually exclusive exons (MX), intron retention (RI), use of alterna-
tive 5’ splice sites (A5), alternative 3’ splice sites (A3) alternative first
(AF) or alternative last (AL) exons. Tools like MISO [77], MATs [78]
or rMATs [79] use spliced alignments of reads to the genome (Figure
1.1 D) in order to calculate the PSI score for each exon. MISO can
be used for alternative splicing analysis of a single sample or for the
comparison of two samples, MATS is used for the comparison of two
samples and rMATs for the comparison of samples with replicates.
Other tools like SUPPA [80] use as input the transcripts abundance
estimates (determined by transcript isoform quantification methods
described above and further discussed in chapter 2) and calculate the
PSI score of each exon by calculating the fraction of the transcripts
that include it over the transcripts that either include or exclude it.
One of the most common forms of alternative 3’ splice sites is the
tandem acceptor sites (at the NAGNAG pattern) [81]. Because these
variants differ by very few (often 3) nucleotides, special care is needed
to make sure they are not treated as errors in sequencing or align-
ment. Similar considerations apply to a recently described type of ex-
ons, called micro-exons, that are especially abundant in neural tissues.
Specialized databases containing these exons are now available [82].
There are other, more complex splicing patterns that are also of inter-
est in specific studies [83]. In many cases there are events that are ob-
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served in specific tissues or health conditions and this information is
missing from existing annotation databases. For this purpose special-
ized databases have been constructed [84] that contain pre estimated
inclusion scores for different tissues and organisms. Finally, special-
ized tools for the quantification of specific splice variations such as
intron retention have also been developed [85] [86] [87] [88].
1.1.6 Alternative polyadenylation analysis
Besides splicing, eukaryotic mRNAs are also modified by the addi-
tion of a cap at the 5’ end [89] and a stretch of poly(A)s at the 3’ end
[89]. The position where transcription is initiated varies, leading to
alternative TSS [90], and similarly, where the poly(A) tail is added
is also not invariant, leading to alternative terminal exons. This de-
pends on the RBPs [91] attached to the region and the availability of
poly(A) sites [92]. Recently, it has been found that some transcripts
differ only in the length of their 3’ untranslated regions (3’ UTRs), one
isoform carrying a long and the other a short version of the 3’ UTR
[93]. Identifying the used poly(A) site (distal or proximal site) is im-
portant because 3’ UTRs interact with many RNA-binding proteins
that determine the traffic, localization stability and translation rate
of the mRNA. Thus, many protocols for sequencing mRNA 3’ ends
have been developed [14] [15] [16] [17]. Corresponding computational
pipelines were developed [94] [95] and databases containing the iden-
tified poly(A) sites have been constructed [96] [97] [98] [94]. However,
some efforts have been initiated to use the vast amount of RNA-seq
data already generated to infer terminal exon isoforms expression.
The usage of alternative promoters (AF) or alternative terminal ex-
ons (AL) (Figure 1.1 C) can be quantified with tools initially built to
study alternative splicing (exon-based or transcript-based approaches
discussed previously). Additionally, RNA-seq based algorithms have
been developed [99] [100] [101] to study the differences in alternative
terminal exons usage. In chapter 2 and chapter 3, we used poly(A)
sites identified from 3’ end sequencing protocols to evaluate the per-
formance of transcript quantification algorithms and identify novel
terminal exons respectively.
1.1.7 Long non-coding RNAs
Deep sequencing has also enabled the discovery and further char-
acterization of many different types of non-coding RNAs. Based on
their length, these are categorized as small non coding RNAs, that
are 20-30 nucleotides long (miRNAs, piRNAs, and siRNAs), interme-
diate length non-coding RNAs of 50 to 150 nucleotides (snoRNAs,
tRNAs, and U snRNAs) and long non-coding RNAs (lncRNAs) that
are 200 bases or longer. LncRNAs can originate from intronic regions
of protein-coding genes, from intergenic regions of protein-coding or
non-coding genes (lincRNAs) or antisense regions of protein-coding
genes (antisense lncRNAs) [102]. LncRNAs may or may not contain
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poly(A) tails [103] and can be detected either in the nucleus or/and
in the cytoplasm [104].
Various methods have been used for the identification of lncRNAs
[105] like 3’ end sequencing for transcript ends and H3K4me3 chro-
matin maps for the identification of transcription start sites [105].
RNA-seq (mainly total RNA-seq) is used for the identification of the
structure of transcripts [106] and the estimation of their expression.
LncRNAs are in general lowly expressed [107], so it is important to
use quantification methods that are accurate in this expression regime.
Some parts of chapter 2 discuss this issue. Transcript reconstruction
algorithms are also crucial for the identification of novel lncRNAs
since this field is relatively new and the set of lncRNAs in databases
is incomplete. Efforts to catalog lncRNAs are described in references
[108] [109] [110]. Chapter 3 discusses transcript reconstruction meth-
ods that we developed in our group to identify novel transcripts in lin-
cRNA regions. An important step apart from the identification is the
characterization of the potential novel lncRNA. Ribosome profiling
provides a good indication of whether a lncRNA can be translated or
not. Computational methods have been developed that use machine
learning approaches to predict if a newly identified transcript can be
classified as lncRNA [111].
1.1.8 Visualization
Visualization is an important part for interpretation of HTS data. Mul-
tiple genome browsers have been developed over the years. Many of
them can be used over the web like the UCSC genome browser [112],
while others are used locally like IGV [113]. R libraries [114] are com-
monly used to visualize genomic tracks. Finally, Sashimi plots [115]
are useful to visualize the splice junctions that are used.
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C O M PA R AT I V E A S S E S S M E N T O F M E T H O D S F O R
T H E C O M P U TAT I O N A L I N F E R E N C E O F
T R A N S C R I P T I S O F O R M A B U N D A N C E F R O M
R N A - S E Q D ATA
2.1 abstract
2.1.0.1 Background
A detailed understanding of the regulation of gene expression, includ-
ing transcription start site usage, alternative splicing and polyadeny-
lation, requires accurate quantification of gene expression levels down
to the level of individual transcript isoforms. To this end, a variety of
methods for estimating transcript isoform abundance from RNA se-
quencing data have been proposed. To comparatively evaluate their
accuracy, we have used both synthetic data as well as an indepen-
dent experimental method for quantifying the abundance of tran-
script ends at the genome-wide level.
2.1.0.2 Results
We found that many tools have good accuracy and that they yield
better estimates of gene-level expression than commonly used “count-
based” approaches. Transcript or gene-level features such as nucleotide
composition and intron/exon structure appear to have little influ-
ence on the accuracy of expression estimates, which correlates most
strongly with transcript/gene expression levels. Finally, we found
large differences in the memory and runtime requirements of the dif-
ferent tools, factors that are likely to be important in their adoption
by the user community.
2.1.0.3 Conclusions
As many methods for quantifying isoform abundance with compara-
ble accuracy are available, a user’s choice will likely be determined
by factors such as the memory and runtime requirements, as well
as the availability of methods for downstream analyses. Sequencing-
based methods to quantify the abundance of specific transcript re-
gions could complement validation schemes based on synthetic data
and quantitative PCR in future or ongoing assessments of RNA-seq
analysis methods.
2.2 background
The general availability of high-throughput sequencing technologies
greatly facilitated the detection and quantification of RNA species,
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including protein-coding RNAs, long non-coding RNAs, and microR-
NAs, in many different systems. In higher eukaryotes, the vast ma-
jority of protein-coding genes express multiple transcript isoforms
[116] [117] [118]. Although a substantial proportion of transcript iso-
forms may result from stochasticity in the splicing process [81] [119],
striking examples of isoform switching with large impact on cellular
phenotypes are also known (for example, [120] [121]). Tissue-specific
splicing patterns have been linked to the expression of specific RNA-
binding proteins [122], some of which appear to act as ’master’ regu-
lators of alternative splicing in individual tissues [123]. For example,
muscleblind-like proteins 1 and 2 (MBNL1/MBNL2) are expressed
in mesenchymal cells and their downregulation facilitates somatic
cell reprogramming [124], while the epithelial splicing regulatory pro-
teins 1 and 2 (ESRP1/ESRP2) establish epithelia-specific patterns of
isoform expression [125]. Nevertheless, despite the long history of the
field, the functional relevance of most isoforms that can be detected
with sequencing approaches remains unclear [126], particularly in
light of the rapid change of isoform usage pattern in evolution that
indicates relatively weak selection pressure [127].
Analysis of expression pattern is often one of the first steps towards
understanding a gene’s function. However, transcript isoform abun-
dance is almost always quantified indirectly; most of the sequencing
technologies that are currently used yield reads that are short (6200
nt) relative to the length of eukaryotic transcripts (2.2 kb in mam-
mals, on average) [128] and thus, a sequenced read can typically be
assigned to more than one isoform. This is not the case with the tech-
nology developed by Pacific Biosciences that enables sequencing of
full-length cDNAs [129]. A drawback of this technology is, however,
that the throughput is relatively low, of the order of 104 transcripts,
which does not allow accurate quantification of transcript abundance.
Furthermore, the error rates are relatively high, making the transcript
identification non-trivial. Thus, accurate and cost-effective quantifica-
tion of the complete repertoire of full-length expressed transcripts,
which are in the range of hundreds of thousands per cell [130], re-
mains an open problem.
As RNA sequencing (RNA-seq) has become commonplace in molec-
ular biology laboratories, a variety of computational approaches has
been proposed for isoform reconstruction from short read sequencing
data (see, for example, [66]). Similarly, quite a number of methods has
been developed for the inference of isoform abundance (reviewed in
[75]). While short read alignment and transcript reconstruction meth-
ods have been extensively benchmarked recently [66] [131], only one
study, rather limited in scope, evaluated some isoform quantification
methods [132]. Independently and comprehensively evaluating the
accuracy of such computational methods is difficult, because exper-
imental validation strategies by, for example, quantitative PCR are
typically restricted to just a limited number of isoforms (see, for ex-
ample, [133]). Developers therefore typically evaluate their tools on
synthetically generated datasets which may not capture adequately
the complexities of RNA-seq experiments.
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In this study we carried out a systematic evaluation of a large num-
ber of methods for isoform quantification from RNA-seq data. We
used not only synthetic, but also genome-wide experimental datasets.
We took advantage of newly developed protocols for quantifying the
abundance of distinct RNA 3’ ends, which result from the use of al-
ternative 3’ end processing sites. These protocols allow a comprehen-
sive surveillance of 3’ end processing site usage, with a method that
is distinct from RNA-seq [14] [134] [16]. From two types of cells and
from two species (human Jurkat T cells or mouse NIH/3T3 cells) we
prepared two libraries, one with an RNA-seq protocol and the other
with a protocol for capturing the 3’ ends of polyadenylated RNAs. We
submitted the aligned RNA-seq reads to the entire panel of compu-
tational methods for estimation of transcript isoform abundance. We
then compared these estimates with those that we obtained indepen-
dently, through the analysis of the corresponding 3’ end sequencing
data.
Our results indicate that many of the available methods have com-
parable accuracy, and that the abundance of highly expressed iso-
forms is more accurately inferred than the abundance of isoforms
with low expression levels. We further found that even the quantifica-
tion of gene expression is more accurate when gene expression levels
are computed by cumulating the levels of transcript isoforms than
when ignoring the transcript structures. Given that many methods
are available that differ little in accuracy, a user’s choice will likely be
determined by factors such as the memory and runtime requirements,
as well as the availability of methods for downstream analyses such
as differential gene/transcript expression.
2.3 results
We initially performed an extensive literature survey to identify tools
that were developed for inferring the abundance of transcript iso-
forms from RNA-seq data. Although we tried to include as many
of these as possible, our study setup required that tools are able to
quantify a set of transcripts that we provided as input, thereby sep-
arating the problem of transcript reconstruction from that of abun-
dance quantification. To be able to interpret the results, we further
focused on methods that have been duly described in the literature.
Lastly, we thought that ease of use would be critical for the adoption
of the tool by the user community and we did not pursue methods
which we were unable to implement within a reasonable amount of
time. Table 2.1 lists the remaining 11 tools, together with their under-
lying principle, input requirements, and references. A description of
how each of the tools was applied is provided in the Methods section.
2.3.1 Runtime and memory requirements differ substantially between tools
Most of the tools that we surveyed have previously been tested by
the developers on simulated data. Here, we have used the Flux Sim-
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Table 2.1: Overview of surveyed methods. The columns are: method name,
sequences to which reads are compared (transcripts or genome), principle
of the method, year of release, and associated reference(s)
Name Reference sequence1 Principle Released
BitSeq Transcripts Bayesian estimation of parameters of a model that
explains the read-to-transcript alignment data. Reads
are assumed to be sampled independently, without
positional bias from transcripts, such that the proba-
bility of an alignment starting at a given position of
a transcript is inversely proportional to the transcript
length. Sub-optimal alignments are used to estimate
the ’background’ of spurious alignments.
2012 [135] [136]
CEM Genome Component elimination expectation-maximization
approach to estimating the parameters of isoform
abundance. For each gene it aims to find a ’sparse’
solution, with few expressed isoforms. Read sam-
pling from isoforms is assumed to obey a quasi-
multinomial distribution, in which positional and
other biases are modeled as an effective distribution
which could be, for example, uniform (no positional
bias) or exponential (modeling the process of RNA
degradation).
2012 [137]
Cufflinks Genome Bayesian approach to estimating transcript abun-
dances by explicitly modeling the length of the frag-
ments expected from RNA-seq. It assumes that for
a given gene, reads are sampled independently with
uniform probability along transcripts and in propor-
tion to the transcript abundance between transcripts.
Thus, if a read can be assigned to two transcripts of
different lengths, the transcript with a shorter effec-
tive length will have a higher probability of giving
rise to the read.
2010 [138]
eXpress Transcripts Similar to Cufflinks, but it includes modeling of er-
rors and indels and it has a different model for frag-
ment length selection. Unlike Cufflinks and most
other methods, eXpress processes read alignments
’on-line’ so that it can be integrated into real-time anal-
ysis pipelines.
2012 [139]
IsoEM Genome Expectation-maximization approach to inferring iso-
form abundances that are consistent with the cover-
age of isoforms by reads. The coverage is assumed
to be uniform along an isoform. Base quality scores
are taken into account in computing the probabilities
of alignments. In the E-step, the expected number of
reads derived from a given isoform is computed and
in the M-step, the relative frequencies of isoforms are
estimated.
2011 [140]
MMSeq Transcripts Models the read data as Poisson-distributed variables
with rates that depend on the abundance of the re-
gions of the transcripts with which the reads are com-
patible and on the sequence-dependent bias in cap-
turing the sequences. Priors on transcript abundances
are Gamma-distributed. Sequencing errors are not
modeled, there is only a filter on the minimal qual-
ity of considered alignments.
2011 [141]
RSEM Transcripts Models the probability of observing a read as the
sum of the relative abundance of the transcript to
which the reads maps times the probability of the
read mapping to the transcript, and infers transcript
abundances by expectation maximization.
2009 [142] [143]
rSeq Transcripts Models read data as Poisson-distributed variables
with rates that depend on the abundance of the re-
gions of the transcripts with which the reads are com-
patible.
2009 [144]
Sailfish2 Transcripts Expectation-maximization method for explaining the
abundance of k-mers inferred from the reads in terms
on the abundance of the transcripts with the associ-
ated k-mer abundances.
2014 [145]
Scripture Genome Transcript abundance is calculated as reads per kilo-
base of exonic sequence per million aligned reads,
given the alignments of the reads to the genome and
the annotated/reconstructed transcript.
2010 [106]
TIGAR2 Transcripts Models the read data in terms of a large number of
parameters which include, beyond the relative abun-
dance of the transcripts, the read length distribution,
the nucleotides, and alignment state and quality at
the first and second position of the read.
2013 [146] [147]
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ulator software [148] to generate reads corresponding to GENCODE-
annotated transcripts Supplementary Figure A.1). To assess how the
runtime complexity, memory requirements, and accuracy of the dif-
ferent programs depended on the sequencing depth we generated
sets of 1, 3, 10, 30, and 100 million single-end reads, the latter two
values being in the range that is currently obtained from sequencing
a typical RNA-seq library on broadly used next-generation sequenc-
ing platforms. We found that the tested programs differ substantially
in their runtimes and memory footprints, as measured under defined
conditions on a dedicated machine (maximum available memory =
64 Gb). As shown in Figure 2.1, the CPU times necessary to process
the different datasets span about three orders of magnitude when a
single processor is used (Figure 2.1 A), and two orders of magnitude
when the multi-threading option (16 cores; Figure 2.1 B) is used. In
particular, the times required to process the alignments of 100 million
in silico-generated reads range between approximately 7 min (IsoEM)
and more than 1 week (TIGAR2) when a single processor is used,
and between about 5 min (IsoEM) and 8 h (RSEM) when 16 cores are
available for the tools that support multi-threading (TIGAR2 does
not). With the exception of Sailfish, runtimes strictly increased with
the number of processed read alignments. Assuming that a method-
specific, but largely sample size-independent time span is required to
index the supplied transcriptome, time complexities for most of the
quantification algorithms appear to be approximately linear. Sailfish’s
runtimes seem to be the highest for the smallest dataset, presum-
ably because the convergence of estimation is slow for small datasets,
when the vast majority of transcripts are sparsely covered. Notably,
Sailfish computes abundances based on raw read sequences rather
than alignments. Thus, whenever alignments are dispensable, a con-
siderable amount of time (typically 1 h or more) can be saved on
sample pre-processing compared to all other methods (refer to [131]
[149], [150] for an overview of ‘mapping’ times for some short-read
aligners and conditions). Enabling multithreading had only a limited
impact on runtimes (Supplementary Figure A.2 A), with several of
the tools hardly benefiting at all (maximum ratio between runtimes
at 1 and 16 cores approximately two-fold or less for CEM, eXpress,
MMSEQ, rSeq, and Scripture). However, RSEM (approximately 5.9-
fold speedup for 30 million reads) and BitSeq (approximately 4.2-fold
speedup for 100 million reads), two methods with the highest single-
processor running times had the highest speedup when multiple pro-
cessors were provided. Memory footprints also spanned almost two
orders of magnitude between tools, both when using a single or mul-
tiple cores (Figure 2.1 C, D). For approximately half of the tools (CEM,
eXpress, MMSEQ, Sailfish, Scripture, TIGAR2) the memory footprint
seems to be largely independent of the sample size. For the remaining
tools (BitSeq, Cufflinks, IsoEM, RSEM, rSeq) the memory footprint
increases with the sample size. Although IsoEM seems to trade off a
relatively large memory footprint (from <10 to >30 GB) for extremely
short running times, we did not observe a general inverse correlation
between the running time and memory usage of individual methods
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(A) (B)
(C) (D)
Figure 2.1: Running time and memory requirements. Transcript isoform
abundances were estimated with each of the indicated methods from in
silico-generated datasets of different ‘sequencing’ depths. The running times
(A and B) and memory footprints (C and D) are shown as a function of
sequencing depth. Programs were run on either one (A and C) or 16 cores
(B and D). Note that TIGAR2 is missing in (B) and (D), because the method
does not support the use of multiple cores
(rs = 0.13 and -0.13 at 100 million reads for 1 and 16 cores, respec-
tively) (Supplementary Figure A.2 B, C).
2.3.2 Most methods infer transcript abundances with good accuracy even
from sparse datasets
Our main objective was to evaluate the accuracy of isoform expres-
sion estimates produced by various methods. Consistent with current
expectations about the number of expressed transcripts in a given
cell type, the read simulation software only assigned non-zero ex-
pression to approximately 10.2% of all transcripts supplied to it as
input (19’004 out of 187’176). To avoid the situation that our results
are dominated by how different methods handle transcripts that are
essentially not expressed, we initially restricted our initial analysis to
the set of expressed transcripts. These were those for which the sim-
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ulation software assumed non-zero expression values. When compar-
ing the abundances of these transcripts as inferred by each method
with the ’ground truth’ (Figure 2.2 A and Supplementary Figure A.3),
we found that nine out of 11 programs exhibit very good performance
(Spearman correlation coefficient rs >0.9 for >107 reads). As expected,
correlations generally improved with increasing library sizes, in a
monotonic fashion and asymptotically towards saturation. For most
methods, estimation accuracies reached a plateau at or around a read
depth of 30 million reads, indicating that further increases in read
depth are unlikely to significantly improve their results. In particular,
Spearman correlation coefficients peaked at above 0.95 for six of the
methods (BitSeq, eXpress, IsoEM, RSEM, Sailfish, and TIGAR2) and
above 0.9 for a further three methods (CEM, MMSEQ, rSeq). Both
Cufflinks and Scripture performed considerably worse than all other
methods, with the corresponding correlation coefficients barely sur-
passing 0.75. The influence of the library size on accuracy varied
somewhat between methods, with the total gain from the sparsest
to the richest dataset ranging from approximately 0.01 (Cufflinks) to
approximately 0.08 (BitSeq). Out of the nine most accurate methods,
MMSEQ appears to be the least sensitive to the influence of read
depth (approximately 0.04 gain in accuracy). In order to rule out
that our chosen metric for measuring accuracy is prone to produc-
ing idiosyncratic results, we have compared it with both the Pearson
correlation coefficient and the root mean square error (Supplemen-
tary Figure A.4 A). The relative performance of the methods changed
only little, indicating that the results were robust with respect to the
metric that we chose. Thus, with few exceptions, all methods pro-
duce highly accurate transcripts isoform abundance estimates even
at moderate read depths.
2.3.3 Explicit modeling of transcript isoforms leads to more accurate esti-
mation of gene expression levels than count-based methods
Gene expression levels are typically derived from RNA-seq-based
data by intersecting the genome coordinates of ’uniquely-mapped’
reads with the loci of annotated genes and taking into account the
length of the transcript that is expressed from a given locus. As may
be immediately apparent, this procedure has several limitations. The
first is that it is generally unclear what transcript to consider for each
locus, when correcting for transcript length. What is typically used
is the total length of the ’union exons’, which is clearly incorrect
when the gene expresses multiple isoforms with different relative
abundances and different sequences of exons. A second drawback is
that the proportion of reads that are discarded depends on the repeat
content of the gene with an unknown impact on the accuracy of gene
expression estimates. Finally, reads that map across splice boundaries
and are informative particularly for estimating the expression of indi-
vidual isoforms, may be discarded by the simple counting procedure.
This problem will preferentially affect expression estimates for genes
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(A) (B)
(C) (D)
Figure 2.2: Influence of sequencing depth and expression levels on the
accuracy of expression estimates. Transcript isoform and gene expression
levels were estimated with each of the indicated methods from in silico-
generated datasets of different ’sequencing’ depths. The accuracy of a
method was assessed in terms of the Spearman correlation coefficient (rs)
between the estimates and the known input levels (’ground truth’) of ex-
pressed transcripts (A) and genes (B). Based on their true abundances, tran-
scripts (C) and genes (D) were distributed across four bins of expression
levels. Estimation accuracies as in (A) and (B) are indicated for each method
and bin. The numbers of transcripts and genes in each bin are indicated
together with the expression ranges that they cover. Estimates are based on
a sequencing depth of 30 million reads
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with a large number of exons and isoforms. Thus, one expects that
even gene-level estimates of abundance are improved by the appro-
priate treatment of transcript isoforms. To test how accurately gene
expression levels could be estimated by the benchmarked methods
compared to count-based methods, we implemented two variants
of count-based gene expression level estimation (’union exon’ and
’transcript’-based counting, see Methods). The first method is both
simple and widely used, but it has the pitfalls mentioned above. The
second method tries to correct some of the inaccuracies of the simple
union exon counting method by taking multi-mappers into account
and avoiding artificial gene structures. If a method provided gene-
level estimates (as is the case for Cufflinks, IsoEM, MMSEQ, RSEM,
and rSeq) by default we used these values, otherwise we aggregated
estimates of transcript abundances to obtain such estimates. We then
compared these gene expression estimates to the true gene expres-
sion levels, which were also derived by aggregating the known iso-
form abundances. When considering only the 12’925 expressed genes
(log2 TPM > -5; approximately 26.5% of all genes), the results (Figure
2.2 B and Supplementary Figure A.5) were qualitatively very sim-
ilar to those that we obtained at the level of transcript expression
(Figure 2.2 A and Supplementary Figure A.3): estimates of gene ex-
pression levels that were produced by or derived from the output
of most methods are quite accurate and the accuracy increases with
sequencing depth towards saturation. Only BitSeq’s gene-level esti-
mates were strongly sensitive to the size of the input library, in the
range of approximately 0.90 for 1 million reads to approximately 0.99
for 30 million reads or more. The same six methods that yielded the
most accurate transcript abundances (BitSeq, eXpress, IsoEM, RSEM,
Sailfish, and TIGAR2) gave the most accurate gene level expression
estimates: all achieved peak Spearman correlation coefficients of 0.98
or higher. CEM, Cufflinks, MMSEQ, and rSeq reached Spearman cor-
relation coefficients of at least 0.95. Scripture, when provided with
more than 1 million reads, was also able to estimate gene expression
with good (rs >0.9) accuracy. In contrast, the count-based methods
only achieved moderate accuracy (maximum rs = 0.89 and rs = 0.86
for the ’union exon’ and ’transcript’ methods). As suggested by the
scatter plots in Supplementary Figure A.5, the limited accuracy of ei-
ther method is largely due to the underestimation of true expression
and, as expected, this short-coming is more pronounced in the ’union
exon’ method. As with the transcript estimates, choosing another met-
ric has little impact on the overall ranking/presentation of results
(Supplementary Figure A.4 B). Taken together, these results clearly
demonstrate that although the accuracy of count-based methods may
perhaps benefit from more elaborate procedures for addressing ambi-
guities in the assignment of reads to loci and transcripts, they still fall
short of methods that probabilistically model the generation of RNA-
seq data, taking into account transcript isoforms and the sampling of
reads from transcripts.
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2.3.4 High expression levels are more accurately estimated than low expres-
sion levels
Higher transcript coverage by reads is expected to increase the ac-
curacy with which transcript abundance is estimated. The coverage
depends on both the depth of sequencing as well as on the tran-
script abundance, and indeed we found that the size of the read
library has a positive influence on the accuracy of expression esti-
mates. To evaluate the extent to which ’true’ abundance influences
the accuracy of transcript abundance estimates, we grouped both ex-
pressed transcripts and genes by their ’ground truth’ expression into
four equally sized bins: low (log2 TPM <0 or 1.1), medium-low (0
or 1.1 < log2 TPM <3 or 4.1), medium-high (3 or 4.1 < log2 TPM
<5.5 or 6.2) and high abundance (log2 TPM >5.5 or 6.2), with the
first and second numbers referring to the ranges for transcripts and
genes, respectively. The overall ranking of tools in terms of their ac-
curacy within expression level bins (Figure 2.2 C, D) largely reflects
what we observed when evaluating the performance on expressed
transcripts or genes (Figure 2.2 A, B). However, the accuracy of tran-
script expression level estimates degrades progressively from high
to low expressed transcripts, with the most drastic drop between the
medium-low and low (less than one transcript in 1 million transcripts)
abundance (correlation coefficients for the most accurate tools change
from approximately 0.75 to approximately 0.4/0.5, at 30 million reads,
Figure 2.2 C). Similarly, estimation accuracies on the gene level differ
little across the three bins of most highly expressed genes (mean rs
= approximately 0.92, 0.87, 0.85 for the ’high’, ’medium-high’, and
’medium-low’ bins, respectively), but drop most strongly for the bin
with the least expressed genes (mean rs = approximately 0.68). Thus,
our analysis confirms the expectation that low abundance and, con-
sequently, sparse transcript coverage leads to noisier estimates of ex-
pression. However, for genes whose expression levels are in the top
three quartiles, the estimates provided by the tools agree very well
with the ’true’ expression levels.
Because different methods appear to handle quite differently tran-
scripts with very low abundance, we sought to further investigate
their accuracy in this expression range in particular. More specifically,
we determined the rates at which: (1) transcripts or genes that are not
expressed are estimated to have non-zero expression (false positive
rate); and (2) transcripts or genes that are expressed and are also in-
ferred by a tool to have non-zero expression levels (true positive rate).
It should be noted that when dealing with real rather than synthetic
datasets, one does not know whether a specific transcript truly had a
copy number of 0 in the sample or not. When no evidence of expres-
sion is found, some of the Bayesian methods (BitSeq and MMSEQ)
strictly assign non-zero ’prior’ expression probabilities to transcripts,
and thus they do not, strictly speaking, produce any ’false negatives’.
Nevertheless, even for these methods it may be relevant to deter-
mine how well very limited evidence of expression is handled, and
whether transcripts with no such evidence really get assigned ’prior’
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expression values. Thus, after consulting the developers, we have as-
signed transcripts with an expression estimate which was essentially
the method-specific prior value an estimate of zero (see Methods),
and then determined the false and true positive rates of all methods.
In general, we found that the surveyed methods vary quite consid-
erably in their ability to make accurate ’present calls’ for transcripts
and genes and that tools that exhibit low false positive rates tend
to falsely assign zero estimates to a higher fraction of transcripts or
genes, as expected (Suppementary Figure A.6). In this category are
IsoEM, RSEM, rSeq, Sailfish, TIGAR2, MMSEQ (’prior’ expression
levels handled as described above), as well as Cufflinks and Scrip-
ture (the latter two only when considering gene level estimates). In
contrast, CEM, eXpress, BitSeq (zeroed ’priors’ as described above),
Cufflinks, and Scripture (on the level of transcripts), and, in an ex-
treme manner, the unmodified estimates from BitSeq and MMSEQ
show the exact opposite behavior. As expected, the rate of true pos-
itive calls increases with increasing read depth, as does the rate of
false positives. The increase in true positive calls is particularly ap-
parent for lowly expressed genes and transcripts, for which the true
positive rate increases steeply up to 30 million reads (Supplementary
Figure A.6 E, F). Overall, deeper datasets yield an increased fidelity of
making present calls. Consistent with these results, the Spearman cor-
relation coefficients, when calculated across all transcripts and genes
(Supplementary Figure A.7 A, B), are considerably lower than when
only expressed features are considered (Figure 2.2 A, B). Given that
most of the annotated transcripts were considered ’not expressed’ in
our synthetic dataset, the tools that trade off specificity for sensitivity
(BitSeq, CEM, eXpress, MMSEQ) were most affected by the inclusion
of not expressed transcripts. Taken together, these analyses indicate
that the amount of starting material, the features of interest, and the
obtained read depth are all among the factors that influence the ac-
curacy of expression estimates and may play a role in the choice of
the method that should ultimately be used for data analysis. Nev-
ertheless, moderate sequencing depth of a few tens of million reads
seems to be sufficient for an accurate estimation of most except the
very lowly expressed transcripts by many of the available methods.
2.3.5 The alignment program and bias correction options have little impact
on the accuracy of abundance estimates
Some of the surveyed methods strongly recommend the use of a spe-
cific short-read alignment program. By default, RSEM even calls such
an aligner (Bowtie) internally. Thus, we asked whether the choice of
alignment program impacts the accuracy of isoform abundance esti-
mates that are produced by these methods. Surprisingly, we found
that the aligner has a relatively small impact on estimation accuracy,
regardless of whether one considers transcripts or genes, and only
expressed or all features (Supplementary Figure A.8). If anything,
with the exception of CEM, all methods performed better when sup-
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plied with read alignments prepared with our custom pipeline that
employs the segemehl aligner than when alignments produced by
either Bowtie1 (MMSEQ, RSEM) or TopHat2 (Cufflinks, Scripture)
were provided. RSEM had the highest gain in accuracy, around rs
= 0.05 or rs = 0.03 on the transcript- and gene-level, respectively. On
the other hand, CEM produced slightly more accurate results when
supplied with TopHat-aligned reads, particularly when considering
all features (gain of rs = approximately 0.08). Correspondence with
CEM’s developers revealed that the program requires the TopHat-
specific SAM/BAM tag ’XA’, which encodes information about the
strand of the transcript to which a read aligns, to correctly parse
multi-fragment reads. Because this tag was not supplied in our in-
put alignment files, CEM was unable to properly parse alignments
that covered splice junctions and therefore produced less accurate es-
timates when supplied with our alignments.
A subset of the methods (CEM, eXpress, IsoEM, RSEM, and Sail-
fish) also attempt to correct various biases that occur during sam-
ple preparation, such as positional (non-uniform distribution of reads
along transcripts), sequencing (depending on the nucleotide composi-
tion of the reads), or mapping (sequencing errors and multi-mapping
reads) biases (see Methods section for details). While in general we
have restricted ourselves to executing each program with the default
parameter settings, we wanted to explore whether bias correction had
an impact on the abundance estimation (Supplementary Figure A.9).
Surprisingly, only the transcript estimates produced by CEM and, to
a lesser extent, IsoEM were affected. For CEM, the largest difference
was observed when considering expressed transcripts, for which bias
correction (default: disabled) had a slight detrimental effect (rs loss
= approximately 0.05). In contrast, the estimates produced by IsoEM
seemed to slightly improve upon enabling the bias correction, but
only when all transcripts were considered (rs gain = approximately
0.02). In all other cases, no appreciable differences were observed
when executing programs with or without bias correction.
2.3.6 Gene/transcript structural features affect the estimates of individual
methods
Next, we aimed to assess the impact of gene structural features on the
accuracy of expression estimates. Specifically, we sorted transcripts
according to their length, proportion of guanines and cytosines nu-
cleotides (’GC-content’), and the number of exons of which they are
composed. Likewise, we sorted genes by the number of annotated
transcript isoforms. Reasoning that the influence of gene structural
features on estimation accuracy is likely to be small compared to
that of expression level differences, we concentrated on transcripts
with mid-range expression, where differences should be most clearly
apparent. For each of the structural features, we then defined non-
overlapping bins containing comparable numbers of transcripts or
genes. Supplementary Figure A.10 shows the expression level dis-
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tributions across the different bins for each of the gene structural
features. For each bin we then calculated Spearman correlation co-
efficients between the ‘ground truth’ expression and the estimates
produced by each of the surveyed methods when supplied with the
30 million read synthetic dataset (Figure 2.3). While none of the an-
alyzed features had a strong and consistent effect on estimation ac-
curacy, we have observed some general trends, as well as method-
specific exceptions. The shortest transcripts are quantified with the
least accuracy by all methods but Scripture (Figure 2.3 A). This ef-
fect cannot be readily explained by differences in expression level
distributions across bins, since the smallest transcripts exhibit, in fact,
the highest median expression (Supplementary Figure A.10 A). More-
over, the accuracy of isoform-level estimates steadily increases with
transcript length for five of the surveyed methods, with eight meth-
ods reporting the most accurate estimates for the longest transcripts.
Nevertheless, differences in the correlation coefficients are moderate,
in the range of approximately 0.04 (BitSeq) to approximately 0.14
(Cufflinks). Similarly, high GC content appears to have a slight, un-
favorable influence on the accuracy of isoform abundance estimates,
with all but CEM and Cufflinks producing the least and the most
accurate estimates for transcripts with high, and low GC content, re-
spectively, and with the differences in the range of approximately
0.02 (BitSeq) and approximately 0.13 (Scripture) (Figure 2.3 B). An in-
triguing phenomenon becomes apparent when analyzing transcripts
according to the number of exons that they contain (Figure 2.3 C):
single-exon transcripts are quantified with the least accuracy by all
but two methods (Scripture and eXpress). The differences in accuracy
relative to bin with the second-lowest accurately are generally small
(in the range of approximately -0.01 for BitSeq to approximately -0.05
for CEM) and thus the effect may, at least in part, be explained by
the previously described influence of transcript length. However, for
Cufflinks this difference is very high (approximately -0.64). Indeed,
Cufflinks fails to produce non-zero estimates for the vast majority
of single-exon transcripts (Supplementary Figure A.11 A), but not for
transcripts containing at least two exons (Supplementary Figure: A.11
B, C). This is not due to an incompatibility between Cufflinks and our
read processing/alignment procedure, because applying Cufflinks to
TopHat2-generated alignments recapitulates the effect (Supplemen-
tary Figure A.11 D, E, F). Interestingly, Scripture exhibits the opposite
effect, producing the most accurate estimates for single-exon tran-
scripts (difference to next-best bin approximately 0.11). When exclud-
ing single-exon transcripts and apart from Scripture, the influence of
exon number is marginal, with differences in accuracy across bins in
the range of approximately 0.01 (BitSeq) to approximately 0.05 (rSeq).
Similar to single-exon transcripts, genes with a single transcript
isoform that generate just one transcript species are least accurately
quantified by most methods except Scripture (Figure 2.3 D). This is to
a large extent a consequence of the fact that single-isoform genes are
in fact those giving rise to single-exon transcripts (621 of 1’322 genes,
that is, approximately 47.0%). Additionally, genes that have only a
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Figure 2.3: Impact of gene structural features on expression estimates. All
transcripts or genes expressed at medium levels (0 < log2 TPM <5.5) were
distributed across bins according to transcript length (A), GC content (B),
the number exons per transcript (C), and the number of transcripts per gene
(D). Ranges of the corresponding values covered by each bin are indicated in
the legends above each chart. In all cases, expression levels were estimated
with each of the indicated methods based on in silico-generated sequencing
data (read depth = 30 million). The accuracy of estimates was measured in
terms of how well they correlate with true expression levels, expressed as
the Spearman correlation coefficient rs, and is indicated for each bin and
method
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small number of associated transcripts also have low expression lev-
els (Supplementary Figure A.10 D). Otherwise, the complexity of the
locus appears to have little impact on the accuracy of isoform abun-
dance estimation: maximum differences in accuracy between bins are
in the range of approximately <0.01 (Sailfish) to approximately 0.09
(rSeq), with seven methods exhibiting differences below 0.01. Taken
together, our results indicate that, apart from a few method-specific
exceptions, the influence of gene structural features on the accuracy
of estimates is small. BitSeq, CEM, eXpress, IsoEM, RSEM, Sailfish,
and TIGAR2 produce the most robust estimates across the assessed
features, with the standard deviations of accuracies across the bins an-
alyzed for each feature being around or below 0.025 (Supplementary
Figure A.12). As an additional quantification of the impact of various
structural features, the P values of the Kolmogorov-Smirnov’s good-
ness of fit tests carried out for the log-ratio of estimated and expected
levels for genes/transcripts in specific bins compared to the entire set
of genes/transcripts with moderate expression level (0 < log2 TPM
<5.5 and 1.1 < log2 TPM <6.2 for transcripts and genes, respectively;
compare categories in Figure 2.2 C, D).
2.3.7 Isoform- and gene-level estimates are consistent across biological repli-
cates
A basic test for any inference method is whether they produce sim-
ilar results when supplied with similar data. For isoform quantifica-
tion, reproducibility was generally tested on data that was generated
synthetically. To investigate this aspect, here we have also prepared
RNA-seq libraries from two batches of cells of two cellular systems,
the murine fibroblast cell line NIH/3T3 and the human T cell line
Jurkat. We then supplied the tools for inferring transcript isoform
abundances with the resulting short reads (Sailfish) or alignments (all
other tools). The replicate agreement, defined as the Spearman corre-
lation coefficient rs between the estimated abundances of (groups of)
transcripts in the two human or mouse replicates, was generally high.
At the gene level, rs ranged from approximately 0.82 for both human
(Cufflinks) and mouse (MMSEQ) to approximately 0.91 (human; Bit-
Seq) and 0.90 (mouse; Sailfish). In contrast, at the transcript level, the
agreement was much lower and varied considerably between tools,
in the range of approximately 0.62 (TIGAR2) and 0.60 (MMSEQ) to
approximately 0.95 and 0.91 (both Scripture) for human and mouse
(Figure 2.4 A and Supplementary Figure A.13 A, respectively). How-
ever, only the estimates produced by Scripture and BitSeq showed
agreements substantially above rs = 0.7. Most methods produce es-
timates that are indicative of stronger fluctuations on the transcript
compared to the gene level (mean difference in replicate agreement
approximately -0.14 and -0.15, for human and mouse), likely because
a large proportion of isoforms are expressed at low levels or not at
all. In a few cases, differences between replicate agreement on the
gene and transcript level exceed 0.2 in at least one species (MMSEQ,
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RSEM, rSeq, Sailfish, TIGAR2). On the other side of the spectrum,
Scripture exhibits a slightly higher agreement between its transcript
than its gene level estimates across both organisms (differences of ap-
proximately 0.09 and 0.06 for human and mouse, respectively). These
behaviors likely reflect differences in the models underlying different
methods, particularly with regard to how they treat low abundance
transcripts and how readily they assign reads to the minor and major
isoforms of a given gene.
2.3.8 3’ end sequencing provides independent estimates of isoform abun-
dance
While the tools for inferring isoform abundance have been quite ex-
tensively tested on simulated data, obtaining independent and com-
prehensive experimental reference data is not trivial. Quantitative
PCR (qPCR) is the experimental method of choice for the quantifi-
cation of transcript abundance. However, despite recent technologi-
cal advances allowing qPCR experiments on a large-scale level, these
methods are still cost- and resource-intensive. We therefore applied
our A-seq-2 protocol [25] to prepare 3’ end sequencing libraries from
the same RNA preparations that were used for RNA-seq and sought
to use 3’ end sequencing-based abundance estimates as an indepen-
dent experimental reference dataset for assessing the accuracy of ex-
pression estimates produced by the benchmarked methods.
To assess the quality of these data we first quantified and com-
pared the usage of annotated 3’ end processing sites that overlap the
ends of GENCODE-annotated transcripts (see Methods) between bi-
ological replicates. We carried out this analysis both at the level of
individual 3’ end processing sites as well as at the gene level. For
the latter, we aggregated the abundance estimates of all 3’ end pro-
cessing sites associated with individual genes. Figure 2.4 B (human)
and Supplementary Figure A.13 B (mouse) depict the Spearman cor-
relation coefficients between 3’ end processing site abundances across
biological replicates, whereas Figure 2.4 C (human) and Supplemen-
tary Figure A.13 C (mouse) show the same on the gene-level. In all
cases, the agreement was very high (rs >0.97), suggesting that gene
expression and 3’ end processing site usage are highly similar in the
replicates that we obtained from both human and mouse cells.
Because in constructing the catalog of 3’ end processing sites from
published data we applied stringent validation criteria, the set of
’known’ sites is probably biased towards those that are used in rel-
atively abundant transcripts. We therefore wondered whether the
agreement between biological replicates is higher when one focuses
only on the GENCODE transcripts that end in a ’known’, annotated
3’ end processing site and that are likely to be polyadenylated. This
was the case for 46’801 human and 26’821 mouse transcripts (corre-
sponding to 25’393 and 17’183 3’ end processing sites, respectively;
see Methods section). We selected these transcripts from the output
of each method and computed again the correlation between the esti-
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Figure 2.4: Agreement between expression estimates for replicates of Ju-
rkat cells. (A) Transcript isoform and gene expression levels were estimated
with each of the indicated methods from two biological replicates of human
Jurkat cell RNA-seq data. The agreement between expression estimates of
the two replicates are indicated as Spearman correlation coefficients rs, both
at the level of transcripts and genes. (B) A-seq-2-based 3’ end processing
site expression level estimates for the two replicates are plotted against each
other. The Spearman correlation coefficient rs is indicated. (C) As in (B), but
gene level estimates are compared. (D) As in (A), but with the addition of
3’ end processing site abundances. For computing expression estimates for
either feature type (transcript, 3’ end processing site, and gene), only those
transcripts are considered that end in annotated 3’ end processing sites (see
main text and Methods for details)
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mated levels of transcripts, 3’ end processing sites, and genes (the lat-
ter two by aggregation; see Methods section) in the two replicates. Fig-
ure 2.4 D and Supplementary Figure A.13 D show the results for the
human and the mouse datasets, respectively. As expected, the correla-
tion coefficients computed based on transcripts with annotated 3’ end
processing sites were, without exception, higher than those computed
based on all GENCODE-annotated transcripts (Figure 2.4 A and Sup-
plementary Figure A.13 A). On the transcript level, Spearman correla-
tion coefficients ranged from approximately 0.74 (TIGAR2) and 0.76
(MMSEQ) to approximately 0.96 and 0.94 (Scripture) for human and
mouse, respectively. For 3’ end processing sites and genes, Spearman
correlation coefficients of at least 0.88 were reached by all methods
for the human and mouse datasets, respectively. The gene expression
level estimates provided by the count-based methods also exhibited
high agreement (>0.9 for both organisms).
Finally, we further filtered the set of considered transcripts by ex-
cluding those whose 3’ ends were not captured in our A-seq-2 dataset.
However, in contrast to synthetic data, where the omission of absent
transcripts led to a strong increase in estimation accuracy, this did
not lead to a further improvement of the correlation between repli-
cate samples (Supplementary Figure A.14 A and B for human and
mouse data, respectively). The reasons for this behavior are at the
moment unclear. Nevertheless, this analysis indicates that estimates
of isoform expression are more reproducible when annotated, and
probably more highly expressed poly(A) sites are considered.
Having established that the RNA-seq data lead to highly repro-
ducible estimates of isoform expression, we asked whether the com-
putationally estimated expression levels within individual replicates
agree with those that were measured experimentally with the A-seq-2
method. As before, we have aggregated the isoform abundance esti-
mates for each 3’ end processing site and these, in turn, for each
gene. Moreover, by selecting 3’ end processing sites that overlapped
the end of exactly one transcript, we were able to assess estimation
accuracy on the level of individual transcripts. As shown in Figure
2.5 A (human) and 2.5 B (mouse), the expression estimates produced
by the surveyed methods are in strong agreement with those based
on A-seq-2 across all samples from both human and mouse, with
the Spearman correlations approaching those obtained on synthetic
data. Agreement between transcript estimates ranges between ap-
proximately 0.67 (Cufflinks) and 0.81 (BitSeq) for the human, and
approximately 0.71 (Cufflinks) and 0.84 (BitSeq) for the mouse data.
When considering 3’ end processing sites that overlapped with the
ends of multiple transcripts, correlations further improve, with Spear-
man correlation coefficients for human and mouse data now in the
range of approximately 0.77 (Cufflinks) to 0.86 (BitSeq), and approxi-
mately 0.85 (BitSeq) to 0.74 (Cufflinks) respectively. For reference, the
corresponding scatter plots for the first replicates of each dataset are
presented in Supplementary Figure A.15 (human) and Supplemen-
tary Figure A.16 (mouse). Finally, aggregation of 3’ end processing
site estimates per gene led to a further increase in agreement by ap-
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proximately 0.04 to approximately 0.08 in both organisms. Assuming
the A-seq-2-based estimates of expression as ’ground truth’, Scrip-
ture (rs = approximately 0.92) and RSEM (rs = approximately 0.88)
delivered the most accurate estimates at the gene level for human
and mouse data, respectively. Importantly, we found that even when
estimating gene-level abundance from biological data, isoform-aware
methods yield more accurate results than the broadly used count-
based methods. Across all methods, level of coarse-graining, and or-
ganisms, the second replicate yields estimates that are slightly more
accurate, likely reflecting a batch effect pertaining to the preparation
of RNA-seq and A-seq-2 sequencing libraries. On all levels, differ-
ences in accuracy between most methods are rather small, similar to
what we observed on synthetic data. Also similarly, enabling or dis-
abling bias correction in those methods that provide such an option
also did not substantially alter the accuracy of estimates on experi-
mental datasets (Supplementary Figure A.17) and in the case of CEM,
we have observed a consistent detrimental effect of bias correction
across transcripts, 3’ end sides, and genes, and in both organisms.
As a practical guideline for those researchers studying non-coding
genes, we also wondered how accurately the surveyed methods can
quantify the expression of different classes of genes. Therefore, we
computed the agreements of expression estimates with those inferred
with A-seq-2 on genes annotated as ’protein coding’, ’lincRNA’ (long
intergenic non-coding RNAs), and ’antisense’ in both human and
mouse. For human, the 12’513 protein coding genes amenable to
quantification by A-seq-2 are considerably more accurately quantified
than lincRNA (739) and antisense genes (739), with Spearman corre-
lation coefficients reaching values of up to approximately >0.85, 0.8,
and 0.7, respectively, for the different gene classes (Figure 2.5 C). The
absolute difference in estimate accuracy across these classes is partic-
ularly striking for Cufflinks, where the Spearman correlation coeffi-
cients are reduced by almost 0.4 when trying to estimate lincRNA or
antisense RNAs rather than protein coding genes. This may reflect the
issue that Cufflinks seem to have with quantification of single-exon
transcripts. Given the differences in median A-seq-2-based expression
levels across each gene class (log2 PPM = approximately 3.73, -0.63,
and -0.49 for protein coding, lincRNA, and antisense genes and con-
sidering both replicates), it is likely that the observed differences in
estimation accuracy are, at least in part, a function of the true expres-
sion levels of these genes. Although the general trend is the same
across the mouse samples, the differences in estimation accuracies be-
tween the different gene types are not as pronounced as in human,
and for some methods the quantification of lincRNA genes is actu-
ally more (rSeq, Scripture) or approximately equally accurate (BitSeq,
TIGAR2) as that of protein coding genes (Figure 2.5 D). This may
reflect the true abundance of these genes because A-seq-2 estimates
of the median expression of lincRNA and antisense gene classes were
somewhat higher for mouse (log2 PPM = approximately 0.00 and 0.10,
respectively) while those for protein coding genes were about the
same (median log2 PPM = approximately 3.67). Taken together, the
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Figure 2.5: Agreement between the expression level estimated computa-
tionally from RNA-seq data and those measured with an independent
experimental method. (A) and (B) Abundances of 3’ end processing sites
in two independent samples (circles: replicate 1, triangles: replicate 2) of hu-
man Jurkat (A) or murine NIH/3T3 cells (B) were quantified with A-seq-2.
Based on RNA-seq data obtained the same cell cultures, the abundances of
transcripts ending at these processing sites were estimated with each of the
indicated methods and aggregated per processing site. 3’ end processing
site estimates were further aggregated per gene. The agreement between A-
seq-2- and RNA-seq-based expression estimates was computed as Spearman
correlation coefficients (rs) for 3’ end processing sites, genes, and transcripts
(when processing sites were associated with exactly one transcript). Refer
to the main text and the Methods section for further details. (C) and (D)
Similar to (A) and (B), but only gene expression level estimates were consid-
ered and Spearman correlation coefficients were computed independently
for different classes of gene biotypes, both for the human (C) and mouse (D)
data. Plotted data represent means of the Spearman correlation coefficients
calculated for each of two replicates
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estimates of isoform expression based on biological data and evalu-
ated against expression measurements obtained with an independent
experimental method validate and recapitulate the most important
conclusions derived from the synthetic data: many of the surveyed
methods are able to estimate isoform abundances with good accu-
racy, particularly when true expression levels are high. Furthermore,
employing any of these tools improves the accuracy of gene expres-
sion level estimates relative to widely used count-based methods.
2.4 discussion
Accurate quantification of gene expression is essential for the under-
standing of gene regulatory processes in health and disease. Due to
its large dynamic range, high reproducibility, and the ability to detect
previously unknown transcripts, RNA sequencing has become the
method of choice for global expression profiling. However, despite
the digital nature of the resulting data, technical limitations (lim-
ited read length and non-uniform transcript coverage) render their
analysis challenging, especially when large and complex genomes of
higher eukaryotes, with frequent repeats and overlapping gene struc-
tures, are involved. Accurate computational methods for RNA-seq
data analysis therefore remain in high demand. This is reflected in
the large number of computational methods for estimating transcript
isoform abundance that were developed over the course of the last
6 years. Naturally, the question arises which method should best be
used in a particular context. Here we have tried to address this ques-
tion in depth, using not only synthetic data, as is typically done when
the computational methods are developed, but also using estimates
that were obtained with an independent experimental method for a
specific type of isoforms, namely those that arise from alternative
polyadenylation. This is because methods for global quantification of
3’ end site usage distinct from RNA-seq are available [16] [151] [152]
[153] and have been used quite extensively to analyze changes of 3’
UTR isoforms across conditions. A drawback of these methods is that
they cannot distinguish between transcripts that are processed at the
same poly(A) site. However, although most mammalian genes have
multiple poly(A) sites, currently, over 60% of the poly(A) sites whose
expression we have been able to measure with A-seq-2 have only one
associated transcript annotated in the human or mouse GENCODE
datasets. Thus, we believe that A-seq (or another method for quanti-
fying the usage of 3’ end processing sites) can offer a good alternative
to qPCR as a comprehensive approach to transcript isoform quantifi-
cation. Nevertheless, as the 3’ end sequencing protocols are relatively
new, it is likely that the computational analysis of these data can be
further improved.
Expecting that most users would – at least initially – run the meth-
ods ’out-of-the-box’, we sought to apply the surveyed methods with
default settings, and departed from this general rule only to test the
influence of specific options that the developers of the methods pro-
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posed. Although we found that neither the use of recommended short
read aligners nor the activation of bias correction generally improved
estimation accuracy, it is likely that the developers of the individual
methods or experienced users would be able to improve the perfor-
mance of individual tools in specific settings. During the course of
this study we discovered a number of assumptions that the programs
tacitly made and that affected the interpretation of the results. There-
fore, a specific recommendation that we can make to developers is to
ensure that sufficiently detailed information on input requirements,
potential pitfalls and the implication of specific options (ideally in-
cluding usage examples) is provided.
Encouragingly, we found that most of the methods that are cur-
rently used to estimate transcript isoform abundance produce quite
comparable and accurate results, both on synthetic and experimental
data. As a general trend, methods such as Scripture and Cufflinks,
whose main objective is to assemble/reconstruct transcript isoforms
but that have also been co-opted for estimating isoform abundance,
perform poorer than methods specifically designed for the latter pur-
pose. However, such methods could be part of the initial assembly
of a comprehensive set of transcripts whose expression can be sub-
sequently quantified with a different approach [66]. Cufflinks is part
of the popular ’Tuxedo Suite’ pipeline (Bowtie-TopHat-Cufflinks) and
for the purpose of inferring isoform abundances from RNA-seq data
is probably superseded by the eXpress method developed by the
same group [139]. Importantly, the gene level expression estimates
obtained by cumulating the abundances of transcript isoforms in-
ferred with almost any of the surveyed methods are more accurate
than those produced by ‘count-based’ methods that are widely used
in the analysis of gene expression. This is likely because count-based
methods either disregard or mis-assign reads whose origin (genomic
locus or isoform) cannot be unambiguously determined. We therefore
strongly advise to use methods for transcript isoform quantification
(such as those benchmarked here) even when only quantification at
the gene level is desired.
Next to a general assessment of the accuracy of expression esti-
mates produced by the tools, we also studied the impact of several
transcript properties on the accuracy of expression estimation. We
found that parameters that directly influence the coverage of a tran-
script or gene by reads, such as sequencing depth and true expression
level, have a positive influence on estimation accuracy, as has been ob-
served before [154]. On synthetic data, disregarding features that are
not expressed led to a strong increase in the accuracy of expression
estimates, particularly on the level of isoforms. Thus, as may be ex-
pected, estimates of low-abundance isoform expression are not very
reliable. How isoforms that are expressed at very low levels (or not
at all) are treated in practice, varies between methods. Most methods
report (or imply) cases of ’zero’ expression and some allow the user
to specify a minimum level of expression for reported transcripts. On
the other hand, BitSeq and MMSEQ do not enforce such a threshold
and instead attempt to assign non-zero priors even to transcripts that
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are not supported by any read, based on factors such as the library
size and transcript length. These solutions represent lower and upper
bounds on the expression of low-abundance transcripts (in contrast to
higher-abundance transcripts, for which precise estimates of expres-
sion are sought). In typical RNA-seq experiments, where many tran-
scripts are expected to be expressed, how precisely absent transcripts
are treated may not be essential. However, in the case of, for example,
single cell sequencing, the proportion of annotated transcripts that
are not detected can be quite large and one should be aware that the
meaning of the expression values that the programs report are not
entirely the same for expressed and not expressed transcripts. Next
to coverage-related factors, we found that the length and GC content
of transcripts as well as the complexity of the gene locus (exons per
transcript and transcripts per gene) have a small impact on the accu-
racy of inferred expression levels, which is probably of more interest
to the developers rather than to the average user.
To ensure the widest applicability of our findings, we have based
our study on single-end, short read (50 nt) data. Illumina’s paired-
end sequencing technology, which has been employed in previous
comparisons of isoform abundance estimation methods [132] [154],
provides additional information that may be used by many of the
evaluated methods to improve the assignment of read fragments to
the correct isoform and thereby the accuracy of abundance estimates.
As has been previously demonstrated [154] [142], [143], increasing the
read length should also enhance the accuracy of abundance estimates,
because it leads to a reduction in the fraction of reads that cannot
be unambiguously assigned to the correct isoform. Indeed, increas-
ing the read length is a current trend in the field of next generation
sequencing. For example, Pacific Biosystems technology now allows
full-length transcript sequencing [129], although at limited through-
put.
While most methods produce comparable and fairly accurate es-
timates of transcript isoform abundance, they differ more strongly
in their computing needs. In some cases, speed comes at the cost
of increased memory requirements, which is evident for example
with IsoEM, which is extremely fast, but uses tens of GB of mem-
ory. Nonetheless, with the increase in the number and size of the
datasets that one typically analyzes, speed and scalability of process-
ing become very important considerations for the utility of a pro-
gram. The recently developed Sailfish is of particular interest in this
regard because its running times scale well within the tested range of
sequencing depths, while the memory footprint remains reasonable.
Moreover, its alignment-free k-mer-based approach disposes of the
time-consuming step of aligning reads to a reference genome or tran-
scriptome. For typical datasets of approximately 100 million reads,
most programs use 1–20 GB of memory and run for 1–2 h. An excep-
tion is TIGAR2, which produces highly accurate expression estimates
that come at the cost of both high running times and high memory
use.
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One important aspect that was beyond the scope of the current
study is that in many studies, the interest is the identification of tran-
script isoforms that are differentially expressed between two condi-
tions, rather than the quantification of isoform abundance in a spe-
cific condition. The estimates of isoform abundance inferred with
the methods that we tested here can in principle be used in subse-
quent statistical tests for differential expression, but the issue of the
underlying model has not been entirely addressed. If sufficient repli-
cates are available, two-sample parametric or non-parametric tests
can be used. However, due to the high costs of RNA-seq experiments,
the availability of more than a few replicates is very rare. Instead,
when the number of replicates is small, accurately accounting for
the different sources of variability in the data is important. Differ-
ential expression analysis based on RNA-seq data is frequently done
with programs such as baySeq [155], DEGSeq [156], DESeq [60], or
edgeR [59] (reviewed in [157]). These programs work on (integer)
count data and use specific models for the number of reads that are
expected from individual ’features’ such as exons or genes. There-
fore, they are not appropriate for the estimate of transcript abun-
dances that are obtained with the programs that we analyzed here.
Fortunately, some of the evaluated programs have additional mod-
ules for differential expression analysis. BitSeq has a built-in func-
tionality for differential expression analysis based on the transcript
expression levels estimated by the tool. The developers of Cufflinks
and eXpress suggest Cuffdiff [158] for gene and transcript differ-
ential expression based on their respective outputs. The developers
of IsoEM suggest the bootstrapping-based IsoDE [159] for differen-
tial expression analysis, but this tool is restricted to comparisons
at the gene-level only. MMSEQ’s developers suggest MMDIFF [160]
which performs model comparisons and takes as input the posterior
summaries from the MMSEQ tables. Alternatively, they provide in-
structions to feed MMSEQ-estimated counts to count-based differen-
tial expression analysis tools like DESeq or edgeR https://github.
com/eturro/mmseq/blob/master/doc/countsDE.md. eXpress and Sail-
fish developers also suggest to feed the supplied (rounded) ’effec-
tive counts’, and ’expected number of reads’, respectively, into one
of the count-based differential analysis tools mentioned above. Fi-
nally, RSEM developers suggest EBSeq [161], a Bayesian differential
expression analysis method for genes and isoforms across two or
more biological conditions. EBSeq is integrated into the RSEM suite
http://deweylab.biostat.wisc.edu/rsem/README.html#de.
2.5 conclusions
In summary, several methods for the inference of transcript isoform
abundance can accurately quantify expressed transcripts even from
relatively small short-read libraries and should thus be adequate for
the analysis of both past and present RNA-seq datasets. Their perfor-
mance is largely not affected by structural features (number of exons,
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transcript length, GC content) of the genes/transcripts, although, as
expected, abundant transcripts are quantified more accurately com-
pared to rare transcripts. Importantly, our analysis indicates that the
explicit quantification of transcript isoforms leads to more accurate
estimates of gene expression levels compared to the ’count-based’
methods that are broadly used currently. Given the wealth of tools
available, the user can largely base his choice of method on crite-
ria related to usability, available processing and memory capacities,
compatibility with pre-existing data processing pipelines, and the de-
sired downstream analyses (see Table 2.2). Especially promising is
the most recently proposed approach that relies on k-mer frequencies,
bypassing entirely the read-to-genome/transcriptome alignment and
thereby enabling analysis of very large collections of samples, such
as those that have started to emerge from patient studies. Develop-
ers may profit from our study setup, particularly our efforts to pro-
vide compatible datasets to tools with quite different requirements
as well as our approach at validating estimation accuracies of a par-
ticular type of isoform with an independent large-scale experimental
method. We propose that methods such as 3 end sequencing and cap
analysis of gene expression (CAGE; [162]), which allow quantifica-
tion of alternative polyadenylation and transcription start sites, re-
spectively, could complement validation schemes based on synthetic
data and quantitative PCR in future or ongoing assessments of RNA-
seq analysis methods, such as, for example, by the MAQC-III/RNA-C
consortium [163].
2.6 methods
2.6.1 Genomes, gene annotations, and transcriptome sequences
The hg19 (human) and mm10 (mouse) genome assemblies were ob-
tained from UCSC Genome Bioinformatics, University of California,
Santa Cruz https://genome.ucsc.edu/index.html. Haplotype chro-
mosome versions were discarded. Releases 19 and M2 of the GEN-
CODE gene annotation sets GENCODE [26] were used for the anal-
ysis of human and mouse data, respectively. Version numbers were
stripped from gene and transcript identifiers. In the human annota-
tion set, all features on the Y chromosome that are present, in iden-
tical form, on the X chromosome have gene identifiers of the form
’ENSGRx’ (with x being a 10-digit number), and the corresponding
features on the X chromosomes have identifiers of the form ’ENSG0x’.
We discarded the former to avoid essentially duplicate features. Se-
quences of annotated transcripts (’transcriptomes’) were obtained from
ENSEMBL (release 74, compatible with GENCODE v19 and vM2)
[164]. Genome and transcriptome sequences in FASTA format were
indexed with segemehl [52].
35
Table 2.2: Features and performance summary of the surveyed methods.
To facilitate a user’s choice of method, we indicate which methods meet
various criteria of usability, functionality, and performance, as follows: ’Ex-
tensive documentation’ - documentation that goes beyond the description
of parameters is provided (document, web page, FAQ which allowed us to
run a given method confidently and without help from developers); ’Stan-
dard file formats’ - the method exclusively operates on the indicated file
formats for transcript sequences (FASTA), gene/transcript annotations (GF-
F/GTF or BED12), read sequences (FASTA or FASTQ), and read alignments
(SAM/BAM as defined in [45] and produced by most modern aligners);
‘Gene-level estimates’ - estimates of expression on the gene level are pro-
vided in addition to those at transcript level; ’Reconstruction supported’ -
the method can also reconstruct transcript models based on the provided
sequencing/alignment data; ’DE analysis’ - the developers make a general
recommendation or provide an integrated solution for differential analysis
of transcript/isoform expression; ‘Efficient multi-threading’ - the method
efficiently makes use of multiple cores (speedup of at least two-fold in at
least three out of five datasets; see Supplementary Figure A.2 A); ’Fast’ -
processing of 100 million synthetic reads or their corresponding alignments
completed in less than 1 h (16 cores and 64 gigabytes provided; see Figure
2.1 B); ’Small memory footprint’ - all synthetic datasets could be processed
with less than 8 gigabytes of memory (independent of the number of cores
used; see Figure 2.1 C, D). Additional details are provided in the main text.
Method Extensive
documen-
tation
Standard
file for-
mats
Gene-
level
estimates
Reconstruction
supported
DE analy-
sis
Efficient
multi-
threading
Fast Small
memory
footprint
BitSeq X X X X
CEM X X X X
Cufflinks X X X X X X
eXpress X X X X
IsoEM X X X X
MMSEQ X X X X X
RSEM X X X X
rSeq X X X
Sailfish X X X X X X
Scripture (X) 3 X X
TIGAR2 X X
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2.6.2 Generation of synthetic sequencing data
To generate in silico reads, we have used the Flux Simulator soft-
ware [148], with the hg19 genome and GENCODE v19 annotation
set processed as described above. Because we focused on the quan-
tification of long RNAs, we further removed from the annotation
set, all entries whose gene or transcript type attributes matched ei-
ther ’miRNA’, ’misc_RNA’, ’rRNA’, ’snoRNA’, ’snRNA’, ’Mt_rRNA’,
or ’Mt_tRNA’. Taking into account the annotated transcripts intro-
duced above as well as a target number of transcript molecules (we
chose 5 million), Flux Simulator randomly assigns expression ranks
to transcripts according to Zipf’s Law. The software then attempts
to model the various steps in a typical RNA-seq library preparation
protocol, including fragmentation, reverse transcription, and PCR am-
plification, to generate reads. We ran Flux Simulator with the options
–express, –library, and –sequence. Additional parameters were sup-
plied in a parameter file as outlined in the Flux Simulator manual
http://sammeth.net/confluence/display/SIM/Home. Flux Simulator
does not natively support generation of directional single-end read
libraries. To obtain these, we instead generated a pool of 692,414,670
paired-end reads from which we then discarded all antisense mate se-
quences, as suggested by the Flux Simulator developers. To facilitate
downstream processing, the identifiers of the remaining reads were
simplified and their sequences capitalized. Identical read sequences
were collapsed with the fastx_collapser http://hannonlab.cshl.edu/
fastx_toolkit/index.html. Finally, poly(A)-tails - introduced in the
simulation - were removed with the cutadapt software [38] by speci-
fying a stretch of 50 adenines as the 3’ adapter and the non-default
options –overlap=1 and –minimum-length=15. This resulted in a set
of 298,435,172 poly(A)-free, directional, single-end reads. From this
initial set, we randomly selected, progressively, approximately 100
(100,001,950), 30 (30,004,152), 10 (10,000,760), 3 (2,998,971), and 1 (999,436)
million reads to analyze the scaling behavior of the programs.
2.6.3 Preparation of sequencing libraries
Human Jurkat T lymphocytes (ATCC TIB-152) [165] and NIH/3T3
mouse embryonic fibroblasts (ATCC CRL-1658) [166] were cultured
in RPMI medium (Sigma) at 37 Celcius and 5% CO2. Cells were col-
lected at approximately 70% confluency after trypsinization. 3’ end
libraries were generated by the A-seq-2 protocol, which captures se-
quences immediately upstream of mRNA 3’ end processing sites and
poly(A)-tails [167], and directional RNA-seq libraries were prepared
according to the Illumina-provided protocol. For both protocols, poly(A)-
positive RNA was isolated from the cells with the ’Dynabeads mRNA
DIRECT Kit’ (Ambion) and fragmented by alkaline hydrolysis to frag-
ment sizes of 150-300 nt. Following reverse transcription and PCR am-
plification, the libraries were sequenced single-end with a read length
of 51 nucleotides on an Illumina HiSeq-2000 platform.
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2.6.4 Pre-processing of human and mouse RNA-seq data
Potential 3’ adapter and poly(A)-tail fragments were sequentially re-
moved from FASTQ-formatted short reads sequences with two iter-
ations of cutadapt [38], specifying the 3’ adapter sequence and a
stretch of 50 adenines, respectively, to the –adapter option. Other non-
default options were –overlap=1 and –minimum-length=15. Identical
sequences were collapsed with the fastx_collapser http://hannonlab.
cshl.edu/fastx_toolkit/index.html.
2.6.5 Alignment of synthetic and experimentally obtained reads to genomes
and transcriptomes
The experimentally obtained sequence sets, as well as the five in
silico-generated read subsets (FASTA-formatted), were aligned to the
genome and transcriptome of the respective species with segemehl
0.1.7 [52], with default parameters (minimum percentage of matches:
90%) and without using the spliced alignment option. Anti-sense
alignments to transcripts were discarded from further analysis. For
the surveyed methods that require input alignments in ’genome space’,
transcriptome alignments were converted to genomic coordinates with
custom scripts based on the gene models provided in the GENCODE
v19 annotation file. Directly and indirectly obtained genome align-
ments in SAM format were merged, duplicate alignments resulting
from the conversion between transcript and genome coordinates were
discarded, and the remaining alignments were filtered such that for
each read only the alignments with the smallest edit distance were
kept. For methods requiring input alignments in ’transcriptome space’,
the transcriptome alignments of each reads that had an edit distance
larger than the minimum distance obtained in aligning the read to
the genome were discarded.
During the course of the study, we have noticed that the transcript
isoform quantification methods that we evaluated make certain as-
sumptions about the format of the input alignment files and that in
some cases these assumptions only hold for certain short read align-
ers or for outdated file formats. We therefore implemented additional
post-processing steps to ensure that the information required by in-
dividual programs is present in the alignment file is the appropri-
ate form. (1) We ’uncollapsed’ the reads: across all alignment files,
alignments corresponding to collapsed reads were ‘cloned’, but a ran-
domized QNAME name was assigned to each individual read that
was only re-used for additional alignments of the same read. (2) To
avoid misinterpretation of tag fields, all custom segemehl tags were
removed. (3) Reads aligning to more than one reference locus are re-
ported by segemehl as individual alignment records with identical
read names (QNAME field). In accordance with the SAM specifica-
tions (http://samtools.github.io/hts-specs/SAMv1.pdf), we have
further added a linked-list encoding for such reads. Specifically, we
have designated the first out of such a group of alignments as the
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primary (0x100 bit of the FLAG field unset) and introduced CC and
CP tags, pointing, respectively, to the reference sequence name and
the starting position of the following alignment. All remaining align-
ments were designated secondary (0x100 bit set), and CC and CP
tags were added to all alignments but the last in the list. Moreover,
the HI (0-based ’hit index’) tag was added to all alignments of ‘multi-
mapping’ reads. The NH (’number of hits’) tag was re-computed for
all reads in a given alignment file. (4) segemehl reports a default map-
ping quality (MAPQ) of 255 for each alignment record. Following the
example of TopHat2 [168], we have reset the mapping quality values
based on the number of alignments reported for a given read. Specif-
ically, we have assigned mapping qualities of 50 (NH = 1), 3 (NH =
2), 1 (NH = 3 or 4), and 0 (NH = 5 or more). (5) We introduced se-
quencing quality strings (QUAL field). For in silico-generated reads,
which did not have such scores associated, strings of ’I’ characters
that match the length of the read sequence (SEQ field) were used
to denote maximum quality scores (according to the Sanger FASTQ
format). In the case of the experimental RNA-seq libraries, we used
the quality scores that were provided in the initial FASTQ files that
were obtained from the sequencing facility. The data processing was
automated with the help of the Anduril [29] data analysis framework.
To test the influence of the alignment program, we have also gen-
erated alignments of in silico generated reads with Bowtie (version
1.0.0) [169] and TopHat2 (version 2.0.10) [168]. The output of these
programs were used without further processing.
2.6.6 Analysis of 3’ end sequencing data
The reads obtained with the A-seq-2 protocol for 3’ end sequencing
have a particular structure: they are the reverse complement of 3’ end
RNA fragments and further have the sequence AAANNNN down-
stream of the actual 3’ end [167] for details). To recover the mRNA
3’ ends from these sequenced reads, we therefore first trimmed the
expected NNNNTTT sequences from the 5’ ends of the reads, re-
moved the 3’ adapter with the removeAdaptor.pl function of the
CLIPZ server [28] and kept only sequences longer than 15 nt. We
reversed complemented the sequences and mapped them to the cor-
responding genome and transcriptome with segemehl v0.1.7 [52] and
default parameters. Next, we transformed transcriptome alignments
to genomic coordinates, merged them with the genome alignments,
discarded duplicates and kept for each read only those alignments
with the smallest edit distance (see above). Finally, we collapsed the
3’ ends of the aligned short reads and produced a BED file record-
ing the exact genomic positions of 3’ end cleavage together with the
aggregated read counts. For reads that mapped to multiple loci in
the genome, counts were equally distributed across loci. As we and
others observed before, 3’ end formation appears to occur with a
certain degree of microheterogeneity, that is, prominent 3’ end sites
are usually being flanked by less frequently used 3’ end sites. Be-
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cause these latter sites may not reflect functional biological variation,
closely spaced 3’ end sites are typically clustered into 3’ end process-
ing regions [16]. Many 3’ end sequencing protocols capture sequences
that result from priming at internal adenosine stretches rather than
poly(A)-tails at the step of cDNA synthesis. To exclude a protocol-
specific bias in 3’ end quantification, we only analyzed 3; end pro-
cessing sites that are supported by at least two independent 3’ end
sequencing protocols. These are annotated in our in-house polyAsite
database [94]. For each 3’ end processing region, we determined the
number of overlapping A-seq-2-inferred 3’ end reads, which we used
as a measure of the expression of the corresponding 3’ end process-
ing region. In total, we quantified the expression of 90,128 and 61,457
3’ end processing regions in human and mouse, respectively.
2.6.7 Estimation of transcript isoform abundance
With the exception of Sailfish (see below), all of the programs com-
pared in this study use alignments of reads to either the transcrip-
tome or the genome. We used the samtools [45] suite to sort or inter-
convert the SAM/BAM alignment files obtained from mapping reads
to genomes/transcriptomes. To detect and quantify ’multi-mapping’
reads, several methods require that the alignment files are ordered
such that the alignments of a given read occur one after the other. Ad-
ditionally, some methods further require that reads that are similar in
sequence (and their associated alignments) are randomly distributed
in the input file. This is of clear relevance for eXpress, which pro-
cesses alignments ’on-line’ and trains its parameters from the data. In
such cases, ’non-random’ occurrence of the read alignments may lead
to biased parameters and output. Typically, both of these conditions
(reads occur in random order while all alignments of a given read are
grouped together) are met when alignments are sorted by the names
of the reads, which is recommended in the documentation of these
methods. But if the pre-processing pipeline includes sorting and re-
naming steps (for example, collapsing and uncollapsing of reads with
identical sequences), sorting the alignment file by read names may
lead to a situation in which neither condition is fulfilled. Unfortu-
nately, the precise assumptions about the order in which read align-
ments should appear in the input file are not typically mentioned in
detail in the documentation of the programs. We thus recommend
that users ensure that the order in which reads appear in the align-
ment file that is used as input to an isoform quantification method is
’randomized’ whenever the quantification method recommends sort-
ing alignments by read name.
Scripture and CEM require annotation files in a BED-based for-
mat which supports multiple fragments (that is, exons) per entry
and is known as BED12 or BED12+3. These were generated from
the GENCODE-provided GTF annotation files with the help of the
R/Bioconductor package rtracklayer [170]. Because some methods re-
quired the mean and standard deviation of the fragment/read length
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distribution, we calculated these from the alignment files with a cus-
tom script. In the following, the steps taken to execute each surveyed
program are outlined.
BitSeq [135] [136] uses as input transcript sequences in FASTA for-
mat and alignments of reads to the transcriptome in SAM or BAM for-
mat, sorted by read name (randomized). We have used the command-
line version of BitSeq (version 0.7.5), but an R/Bioconductor version
is also available.
The first step in BitSeq is to parse the alignment file to calculate
probabilities of individual reads originating from individual transcripts:
parseAlignment <alignments_transcriptome> \
--trSeqFile <sequences.fa> \
--outFile <out_prefix.prob> \
--trInfoFile <out_prefix.trx> \
--uniform
Then the mean transcript expression is estimated with a Variational
Bayes inference algorithm:
estimateVBExpression <out_prefix.prob> \
--outPrefix <out_prefix> \
--outType RPKM \
--trInfoFile <out_prefix.trx> \
--samples 1000 \
--seed 1
By default, when no read alignments are assigned to a given tran-
script, BitSeq sets the expression estimate of the transcript to a ’prior’
that depends on the effective transcript length and the sequencing
depth. When indicated and in communication with the developers,
we have identified these cases by finding transcripts for which the
expected read count (alpha parameter of the Dirichlet distribution)
equals exactly 1 and replaced their RPKM estimates with zeros.
CEM [137] takes as input a BED12 file of transcripts and a SAM or
BAM file of genomic alignments, sorted by genomic coordinates. We
ran CEM (processsam version 2.5.2) as follows:
python runcem.py \
--annotation <annotations.bed12> \
--forceref \
--prefix <out_prefix> \
<alignments_genome.bam>
Where indicated, we have set the –usebias option to evaluate CEM’s
built-in bias correction functionality, which attempts to correct for
positional, sequencing, and mappability biases.
Cufflinks [138] takes as input an annotation file in GTF format and
a SAM or BAM file of read alignments to the genome, sorted by ge-
nomic coordinates. We ran Cufflinks version 2.1.1. with the following
command:
cufflinks \
--GTF <annotations.gtf> \
--library-type fr-secondstrand \
--frag-len-mean <fragment_length_mean> \
--frag-len-std-dev <fragment_length_sd> \
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--multi-read-correct \
--output-dir <out_dir> \
<alignments_genome.bam>
Only expression estimates with ’fpkm_status’ ’OK’ were considered.
All other estimates were set to zero.
eXpress [139] takes as input a FASTA file of transcript sequences
and a SAM or BAM file of transcriptome alignments, sorted by read
name (randomized). We ran eXpress version 1.5.1. with the following
command:
express \
--no-update-check \
--f-stranded \
--frag-len-mean <fragment_length_mean> \
--frag-len-stddev <fragment_length_sd> \
--output-dir <out_dir> \
<sequences.fa> \
<alignments_transcriptome.bam>
As eXpress is correcting for biases introduced during library prepa-
ration (specifically, fragmentation and priming) by default, we have
set the –no-bias-correct option when evaluating the performance of
methods without bias correction.
IsoEM [140] takes as input a GTF file with transcript annotations
and a SAM file of genomic alignments, sorted by read name (random-
ized). We obtained instructions for running IsoEM from
(https://dna.engr.uconn.edu/software/IsoEM/README.TXT) and ran
the program (version 1.1.1) as follows:
isoem \
--GTF <annotations.gtf> \
--fragment-mean <fragment_length_mean> \
--fragment-std-dev <fragment_length_standard_deviation> \
--directional \
-o <out_file> \
<alignments_genome.sam> \
IsoEM also attempts to correct for fragment sampling biases result-
ing from random hexamer priming during reverse transcription and
to evaluate this functionality, we have generated isoform abundance
estimates with the -b option.
MMSEQ [141] (version 1.0.8) takes as input a file with transcript se-
quences in FASTA format as well as a BAM file with read alignments
to the transcriptome, sorted by read name (randomized). We ran
MMSEQ based on the provided instructions (https://github.com/
eturro/mmseq). In particular, we first mapped reads to transcripts:
bam2hits <sequences.fa> \
<alignments_transcriptome.bam> > <hits>
and then obtained expression level estimates via:
mmseq <hits> <out_prefix>
Note that unlike all other methods, MMSEQ does not report RPKM
values, but rather the means µ of the posterior isoform expression
distributions. As these are reported as log (base e) values, we first
42
exponentiated them for our analyses. Similar to BitSeq, MMSEQ de-
faults to assigning ’prior’ expression estimates to those transcripts for
which no read/alignment evidence can be found. Where indicated,
and in communication with the developers, we have identified such
cases by substituting in MMSEQ’s output the log µ estimates for all
transcripts or genes with a ’unique_hits’ count of 0 with ’NA’.
RSEM [142] [143] (version 1.2.18) works on alignments of reads
to transcripts (sorted by read name/randomized in SAM or BAM
format). Based on GENCODE annotations, we first generated a tab-
delimited lookup table between ENSEMBL gene (first field) and tran-
script IDs (second field). For each organism (human or mouse), we
then generated RSEM-specific indices of the corresponding ENSEMBL
transcript sequences (FASTA) with the following command:
rsem-prepare-reference \
--no-polyA \
--transcript-to-gene-map <gene_id_transcript_id_table> \
<sequences.fa> \
<index_prefix>
RSEM requires read alignments to the transcriptome. However, be-
cause the tool cannot process alignments that contain insertions or
deletions (indels), we purged the alignment file of any entries that
contained disallowed characters in their CIGAR string fields (D, H,
I, N, P, S). After recalculating read length distributions across the re-
sulting alignment files, we estimated maximum likelihood expression
levels as follows:
rsem-calculate-expression\
--sam \
--strand-specific \
--no-qualities \
--seed-length 15 \
--fragment-length-mean <fragment_length_mean> \
--fragment-length-sd <fragment_length_sd> \
<alignments_transcriptome.sam> \
<index_prefix> \
<out_dir>
To evaluate RSEM’s built-in bias correction functionality, which at-
tempts to correct protocol-specific 5’ or 3’ positional biases, we have
set the –estimate-rspd (read start position distribution) option where
indicated.
rSeq [144] takes as input a FASTA file of transcript sequences and
a SAM file with read-to-transcript alignments, sorted by transcript
names and coordinates. Because the header for each transcript in the
sequence file is expected to be of the form ’gene_id ’ ’transcript_id’,
we used custom scripts to construct these identifiers and substitute
the reference sequences in the sequence dictionary and alignment
entries of the transcriptome alignment file accordingly. We then ob-
tained rSeq-based (version 0.2.0) isoform expression levels with the
following command:
rseq expression_analysis \
<sequences.fa> \
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<alignments_transcriptome.sam>
Sailfish [145] (version 0.6.3) takes as input transcript sequences in
FASTA format and sequenced reads in FASTQ (or FASTA) format.
Sailfish does not required reads to be ordered in a specific manner.
The first step in running Sailfish is to index the transcriptome se-
quences:
sailfish index \
-t <sequences.fa> \
-o <index> \
-k 20
and then the isoform abundance estimates are obtained with the fol-
lowing command:
sailfish quant \
-i <index> \
-l T=SE:S=S \
-r <reads> \
-o <output_prefix>
Sailfish considers transcript length, GC content, and dinucleotide fre-
quencies as possible sources of bias and uses a regression model to
correct for them. By default, Sailfish reports its output both with and
without these ’bias correction’ settings. Unless otherwise noted, we
have used the estimates without bias correction.
Scripture [106] (archive ScriptureScorer.jar provided by the devel-
opers on 6 March 2014) is a tool that was designed for reconstructing
and estimating the relative likelihoods of different isoforms. Scrip-
ture takes as input a file of transcript annotations (in BED12 format)
and a SAM or BAM file with read-to-genome alignments, indexed
and sorted by coordinates. We ran Scripture based on instructions
provided to us by its developers as follows:
java -Xmx<XX>g -jar ScriptureScorer.jar \
-annotations <annotations.bed> \
-alignments <alignments_genome.bam> \
-strand <first> \
-singleEnd \
-minMappingQuality 5 \
-out <out_file>
TIGAR2 [146] [147] (update from 6 March 2014) takes as input a
FASTA file of transcript sequences and a SAM or BAM genome align-
ments file, sorted by read name (randomized). We used the following
command to run TIGAR2:
java -Xms<XX>g -Xmx<XX>g -jar Tigar2.jar \
<sequences.fa> \
<alignments_genome.bam> \
--alpha_zero 0.1 \
<out_file>
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2.6.8 Normalization and stratification of expression ’ground truths’ and
estimates
In order to assess the accuracy of expression level estimates, we first
converted the ’ground truth’ transcript abundances provided in the
Flux Simulator output for the simulated data and the by the A-seq-
2 data (processed as described above) for the human and mouse
samples to a standard library size of 1 million reads. We refer to
these measures as transcripts per million transcripts (TPM) and pro-
cessing regions per million processing regions (PPM), respectively.
Since the benchmarked methods already supplied estimates in nor-
malized expression units, no further processing of these values was
required. In particular, we have used the reads/fragments per kilo-
base of exon model per million mapped reads (RPKM/FPKM) units
wherever available, thus accounting not only for differences in library
sizes but also for differences in transcript lengths. The latter is neces-
sary because the number of fragments obtained from a given RNA
during library preparation, and thus the read count for that tran-
script, is proportional to its length [61]. Only in the case of MMSEQ
we have used the exponential of the reported means of the posterior
distributions µ instead of RPKM (see above). However, these units
are largely equivalent as they both control for sample size and fea-
ture length [141]. In cases where estimates were absent for individ-
ual transcripts, these were set to zero. For the comparisons of RPKM
estimates with A-seq-2-based estimates (human and mouse), only
those poly(A)-processing regions were considered that correspond to
the ends of transcripts annotated in the GENCODE annotation sets
(and vice versa). However, to account for the fact that only poly(A)-
containing transcripts are efficiently captured by our sequencing li-
brary preparation protocols, we only considered transcripts which we
presume could have been polyadenylated (annotated as either ’anti-
sense’, ’lincRNA’, ’nonsense_mediated_decay’, ’processed_pseudogene’,
’processed_transcript’, ’protein_coding’, or ’retained_intron’). RPKM
estimates for the remaining processing sites (25’393 and 17’183 for
v19 human assembly version and M2 mouse assembly version, re-
spectively) were then obtained by summing the RKPM values of
the transcripts ending at individual poly(A)-processing regions. Sim-
ilarly, we calculated gene-level expression estimates by summing the
RPKM values of all transcripts (simulated data) or the TPM values of
all processing regions (human and mouse data) annotated for each
gene. Some of the benchmarked methods (Cufflinks, IsoEM, MM-
SEQ, RSEM, and rSeq) already provide gene-level estimates. How-
ever, for Cufflinks and MMSEQ these are not fully equivalent to the
sums computed as described above. In the case of Cufflinks, this is ap-
parently because of residual counts that could not be confidently as-
signed to any of the isoforms of a gene, since in the transcript output
for that method (’isoforms.fpkm_tracking’) there is reported for each
gene an estimate that accounts for the difference between the sum
of transcript isoform estimates and the gene expression estimates re-
ported in a separate file (’genes.fpkm_tracking’). For MMSEQ, gene
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level estimates are produced by aggregating the Markov chain Monte
Carlo traces for the transcripts originating from a gene locus. When-
ever gene-level estimates of expression were directly reported by a
method, we have used these. As with transcripts, missing gene ex-
pression estimates were set to zero.
2.6.9 Count-based gene-level estimates of expression
Although our primary interest was to assess the accuracy of meth-
ods for isoform expression profiling, a lot of studies rather limit
themselves to gene-level estimates of gene expression. The question
then arises of how the methods that are used for obtaining gene-
level estimates compare with those that are specifically designed for
estimating isoform abundance but can be co-opted for the estima-
tion of gene-level expression levels as well. One method for estimat-
ing gene-level expression is ’union exon’-based counting. To imple-
ment this method we have selected the exon entries from the GEN-
CODE annotation files, grouped them by the ENSEMBL gene iden-
tifier, and merged overlapping exons for each gene. When analyz-
ing human or mouse data, we have discarded the exons of tran-
scripts that do not end in annotated poly(A)-processing regions or
that are unlikely to be polyadenylated, analogous to the filtering that
we applied to transcripts used in the benchmarking (see above). We
then generated per-gene counts by intersecting the genomic align-
ments of the different datasets with the resulting ’pseudoexons’, us-
ing the function summarizeOverlaps of the R/Bioconductor pack-
age GenomicAlignments [171] with options –ignoreStrand=FALSE,
–mode=’IntersectionStrict’ and –interFeature=TRUE. While this pro-
cedure prevents double-counting of reads and is frequently applied
in the context of gene counting in RNA-seq experiments, reads align-
ing to multiple genomic loci as well as those aligning to loci for
which more than one feature is annotated are not considered. Ad-
ditionally, many read alignments covering exon-exon-junctions are
discarded because these exon-exon junctions are not part of the set of
junctions between pseudo-exons. To appropriately handle such cases
we implemented also a ’transcript’-based counting method as follows:
We used the R/Bioconductor package rtracklayer [170] to convert the
GENCODE-annotated exons of either all (in silico-generated data) or
the filtered set of transcripts (human and mouse data; see above) to
the BED12 / BED12+3 format, a tabular format able to encode gaps.
We then intersected the genomic alignments for each dataset with the
corresponding annotation file using bedtools mode intersect [57] such
that overlaps were only reported if the entire read alignments, includ-
ing the gaps that could correspond to introns, matched the transcript
alignments on the sense strand (options -s and -f 1). The resulting
overlaps were summarized, further distributing reads equally to all
(possibly overlapping) annotated loci to which they aligned with the
same edit distance. Thus, we first determined the number of genomic
loci l for which overlaps were reported for a given read. For each
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of these, we then added 1∑l
i=1 gi
to the total count of all genes that
give rise to one or more transcripts from a locus i. For each library,
the counts produced by each of these counting methods were then
converted to RPKM by dividing by (1) the total number of reads that
could be successfully aligned to the genome and (2) the total length
(in nucleotides) of the ’union exons’ (see above) of the considered
transcripts, followed by multiplication by 1 billion.
2.6.10 Evaluating the accuracy of gene/isoform abundance estimates
We assessed the accuracy of the methods in terms of Spearman cor-
relation coefficients between the known (simulated data) or indepen-
dently estimated abundances (A-seq-2) and the abundances inferred
with the individual methods. Depending on the type of data and anal-
ysis, we applied this procedure on the level of transcripts, poly(A)-
processing regions, and/or genes, either considering all features or
subsets thereof, grouped by common features (for example, expres-
sion ranges, structural). Where indicated, we have further computed
the Pearson correlation coefficient and the root mean square error.
In these cases, we have first set all expression levels (true or esti-
mated) below 0.03125 (the log2 of which is -5) to that value and log2-
transformed the resulting ’pseudocount’-adjusted values.
2.6.11 Availability of supporting data
Raw sequencing (RNA-seq and A-seq-2) and in silico-generated read
files are available in the Sequence Read Archive (SRA) http://www.
ncbi.nlm.nih.gov/sra repository under accession SRP051039 http:
//www.ncbi.nlm.nih.gov/sra/?term=SRP051039. As the SRA currently
only supports the deposition of read alignments to genomic sequences,
we have hosted the processed transcriptome alignment files, corre-
sponding to the simulated/synthetic and experimental (RNA-seq)
read libraries, on our companion website http://www.clipz.unibas.
ch/benchmarking. The page further includes information on where to
find the benchmarked methods, all source code - organized in well
documented convenient wrappers that allow easy recreation of ei-
ther the whole study or parts thereof - and an online analysis ser-
vice where users can upload expression estimates inferred from the
datasets used in this study and compare them to the methods (or
their specific versions) assessed here.
2.7 acknowledgements
We are grateful to Peter Glaus, Magnus Rattray, Antti Honkela (Bit-
Seq), Wei Li (CEM), Cole Trapnell (Cufflinks), Ernest Turro (MMSEQ),
Colin Dewey (RSEM), Hui Jiang (rSeq), Rob Patro (Sailfish), Sabah
Kadri (Scripture), and Naoki Nariai (TIGAR2) for providing valuable
assistance with this study. We apologize to the developers of tran-
script isoform quantification methods that were not included in this
47
survey because they could not be implemented, did not meet the
requirements imposed by our study design or that we simply did
not find in our initial method search. We thank Christoph Rodak for
help with setting up the companion website and Manuel Belmadani
for contributing scripts for the A-seq-2 analysis. This work was sup-
ported in part by a Sinergia grant from the Swiss National Science
Foundation (CRSII3_127454), a Marie Curie Initial Training Network
(project #607720, RNATRAIN), and a Starting Grant from the Euro-
pean Research Council (#310510, WHYMIR).
48
3
T E R M I N A L E X O N C H A R A C T E R I Z AT I O N W I T H
T E C T O O L R E V E A L S A N A B U N D A N C E O F
C E L L - S P E C I F I C I S O F O R M S
3.1 abstract
Sequencing of RNA 3’ ends has uncovered numerous sites that do
not correspond to the termination sites of known transcripts. Through
their 3’ untranslated regions, protein-coding RNAs interact with RNA-
binding proteins and microRNAs, which regulate many properties,
including RNA stability and subcellular localization. We developed
the terminal exon characterization (TEC) tool (http://tectool.unibas.
ch), which can be used with RNA-sequencing data from any species
for which a genome annotation that includes sites of RNA cleavage
and polyadenylation is available. We discovered hundreds of previ-
ously unknown isoforms and cell-type-specific terminal exons in hu-
man cells. Ribosome profiling data revealed that many of these iso-
forms were translated. By applying TECtool to single-cell sequencing
data, we found that the newly identified isoforms were expressed
in subpopulations of cells. Thus, TECtool enables the identification
of previously unknown isoforms in well-studied cell systems and in
rare cell types.
3.2 introduction
Most eukaryotic transcripts undergo maturation through 3’-end cleav-
age and polyadenylation (CPA). The 3’ untranslated regions (3’ UTRs)
of protein-coding messenger RNAs (mRNAs) interact with RNA-binding
proteins (RBPs) [91] and microRNAs (miRNAs), which control di-
verse aspects of gene expression [172]. Global changes in 3’-UTR
length have been observed during immune responses [173] and de-
velopment [174], as well as in cancers [99]. It was initially thought
that 3’-UTR shortening serves to counteract the repressive effect of
miRNAs in proliferating cells [173] [175]. However, subsequent stud-
ies found largely similar decay rates of long and short 3’-UTR iso-
forms [176] [167], which left the role of changes in 3’-UTR length
unclear. Evidence is accumulating that 3’-UTR-located sequence el-
ements, particularly those that are uridine (U) rich, regulate many
aspects of gene expression, from alternative polyadenylation in the
nucleus to the subcellular localization of mRNAs and proteins in the
cytoplasm [94] [177] [16].
In spite of many efforts to catalog human and mouse transcript iso-
forms [97] [15] [178] [179], sequencing of RNA 3’ ends continues to
uncover novel polyadenylation (poly(A)) sites (PASs), many of which
are outside of annotated exons [97] [15] [178] [179]. The presence of
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well-characterized poly(A) signals indicates that these PASs are gen-
uine [94], yet little is known about their regulation and functions. In
a recent study [94], we identified 108,932 PASs in genomic regions
annotated as introns in the GENCODE transcript annotation, version
19 (ref. [26]). In contrast to the more studied tandem PASs in 3’ UTRs,
whose variable processing leads to changes in 3’-UTR length, the
use of ’intronic’ PASs can alter both the encoded protein isoforms
and the 3’ UTRs, and thus the interactomes of the corresponding
transcripts. To expand genome annotations with transcripts that end
at currently intronic PASs, we developed a computational terminal-
exon-characterization tool, TECtool.
3.3 results
3.3.1 Prevalent RNA processing at intronic poly(A) sites
A large proportion of PASs reproducibly identified from ∼200 dis-
tinct human and mouse 3’-end sequencing samples were located in
genomic regions currently annotated as intronic [94]. Representing
up to ∼10% of the PASs identified in individual tissues (unrelated
to sequencing depth; Figure 3.1 A and Supplemetary Figure B.1 A),
intronic PASs had canonically positioned poly(A) signals (∼21 nu-
cleotides (nt) upstream of PASs; Figure 3.1 B and Supplemetary Fig-
ure B.1 B) but a more specific tissue distribution than the PASs in
annotated terminal exons (Figure 3.1 C and Supplemetary Figure B.1
C).
3.3.2 TECtool identifies terminal exons from RNA-sequencing data
3’-end sequencing data remain relatively scarce. However, public databases
contain many RNA-seq datasets, from a wide range of cell types that
provide evidence for as-yet-unannotated transcript isoforms (Figure
3.2 A and Supplementary Figure B.2). TECtool identifies terminal ex-
ons and transcript isoforms ending at intronic PASs (Figure 3.2 B, C).
On the basis of alignments of RNA-seq reads resulting from single-
or paired-end sequencing (Supplementary Figure B.3), TECtool trains
a model (Supplementary Figure B.4 A) to distinguish terminal ex-
ons from internal exons and background regions, using a variety of
features that reflect differences in the coverage of these regions by
RNA-seq reads (Supplementary Figure B.5). It then uses the model
to predict previously unknown terminal exons, corresponding tran-
scripts, and their putative coding regions. TECtool can also be ap-
plied to data from unstranded protocols (e.g., Illumina TruSeq RNA
v2). In this case, it does not predict terminal exons that overlap with
annotated exons encoded on the opposite strand. To analyze data
from single cells, where most transcripts are only sparsely covered by
reads, we designed a TECtool workflow that initially pools the reads
to infer novel transcripts, and then quantifies the abundance of these
transcripts in individual cells (Supplementary Figure B.6).
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Figure 3.1: Cell-type-dependent use of intronic PASs. (A) Top, percentage
of intronic PASs in individual samples obtained with the 3’-Seq protocol
[180]. Bottom, corresponding sequencing depths. (B) Position-dependent fre-
quency of the canonical poly(A) signal (AAUAAA; dashed line at -21 nt)
upstream of intronic PASs (orange) and of PASs from annotated terminal
exons (blue) from the study represented in A. (C) Distribution of the num-
ber of distinct samples in which individual PASs were observed, for PASs
from terminal exons with no stop codon annotated downstream (terminal
exon; 26,894 PASs), from annotated terminal exons located upstream of an
annotated stop codon in the corresponding gene (terminal exon (ds stop);
3,430 PASs), and from genomic regions currently annotated as intronic (in-
tron; 3,937 PASs). Black boxes indicate the interquartile range (IQR), blue
dots indiate the median, whiskers corresponding to 1.5 times the IQR from
the hinge, and densities extend to the most extreme values.
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Figure 3.2: Example and model to identify novel 3’-UTR isoforms. (A)
Sashimi plots [115] of RNA-seq reads mapped to a region in the locus
for coiled-coil domain containing 173 (CCDC173), with the annotated EN-
SEMBL transcripts (blue), the PASs annotated in the PolyAsite atlas (vertical
black lines; http://polyasite.unibas.ch), and densities of RNA-seq reads
(gray) from fallopian tube and testis samples. The novel terminal exon is
marked by the red dashed box, gray arcs indicate putative splice junctions,
and numbers on the arcs indicate supporting reads (for clarity, only splice
junctions supported by at least 10% of the maximum number of split reads
between two exons in the genomic locus are shown; also see Supplemen-
tary Figure B.2 A). (B) Flow of data through TECtool (input and output
file formats are indicated in parentheses). (C) Outline of the main computa-
tional steps. Step 1, selection of PASs located in regions that, with respect
to the input annotation, are intronic (red arrow) and not exonic, intergenic,
or antisense (black arrows). Step 2, identification of the feature region of the
putative novel terminal exon (red line), extending from the intronic PAS up
to the closest annotated exon upstream (blue box with red border). Step 3,
identification of reads that map uniquely to the feature region. Step 4, defi-
nition of terminal exon boundaries (red box), given by a splice site at the 5’
end, inferred from split reads, and the intronic PAS at the 3’ end. Classifi-
cation of putative terminal exons is done with a Bayes classifier. Step 5, the
newly identified terminal exons are linked to upstream exons to which they
were found to be spliced on the basis of split reads, to generate previously
unknown isoforms. Step 6, prediction of protein-coding regions in newly
identified transcripts.
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3.3.3 TECtool reproducibly and accurately identifies transcripts
To evaluate TECtool, we took advantage of extensive datasets gener-
ated from human embryonic kidney (HEK) 293 cells. The ’support
level’ annotation of individual transcripts in ENSEMBL [25] provides
a natural way to validate the tool, as we can determine whether iso-
forms that are predicted as novel relative to the annotation with the
strongest experimental support (transcript support level (TSL) 1) are
present in the annotation with more limited experimental evidence.
From two biological replicates of RNA-seq in HEK293 cells [181],
TECtool identified 327 and 337 terminal exons (510 in total and 154
in common) that were novel with respect to TSL1 annotation. We
found that 321 of the 510 exons overlapped with terminal exons from
the TSL1–5 annotation, and both annotated and novel transcripts had
very reproducible expression in the two replicates (Supplementary
Figure B.7 A). When we repeated the inference starting from the
known TSL1–5 transcripts, we obtained 170 and 150 novel terminal
exons in the two replicates (250 total, 70 common), which were similar
in properties to transcripts identified starting from TSL1 annotation
(Figure 3.3 A). These results show that TECtool is able to identify
many previously unknown terminal exons even from a highly stud-
ied cell line such as HEK293.
Ribosome profiling data from HEK293 cells [182] revealed that the
identified terminal exons had much higher translational efficiency
than intronic sequences, but lower efficiency than already annotated
terminal exons (Figure 3.3 B and Supplementary Figure B.7 B). The
ribosome footprint density peaked around stop codons, whether al-
ready annotated or predicted in the novel terminal exon isoforms
(Supplementary Figure B.7 C). These results indicate that TECtool-
predicted isoforms are sufficiently stable to undergo translation.
The median lengths of TECtool-predicted terminal exons in the two
HEK293 RNA-seq samples were 732 and 632 nt, respectively, which
are longer than the median lengths of terminal exons predicted by
StringTie [183] (380 and 412 nt, respectively) and Cufflinks [138] (199
and 232 nt, respectively), the two currently most accurate transcript
reconstruction methods [67] (Figure 3.3 C). TECtool did not predict
any exon shorter than 50 nt, in contrast to StringTie (3.5% and 3.9%
of terminal exons in the two replicates, respectively) and especially
Cufflinks (21.5% and 22.4%, respectively). This is a reflection of tran-
script reconstruction tools being largely unable to correctly determine
transcript 3’ ends, where the coverage by RNA-seq reads is reduced.
Consistent with accurate PAS assignment, only TECtool-predicted ter-
minal exons had the canonical poly(A) signal (AAUAAA) at the ex-
pected position, ∼21 nt upstream of PASs (Supplementary Figure B.7
D). In fact, only a minority of intronic terminal exons predicted by
Cufflinks (32.4% and 31.4%) and StringTie (45.5% and 48.6%) had ex-
perimentally identified intronic PASs in the region +/-200 nt from
their 3’ end (Figure 3.3 D). Even when we defined unique terminal
exons solely by their splicing-determined 5’ end, TECtool made more
reproducible predictions from replicate samples (40% of the union of
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predicted exons were identified from both replicates, compared with
30% for StringTie and 18% for Cufflinks; Supplementary Figure B.7
E,F), whereas its predictions were largely not covered by the other
tools (58% or 63% of its predicted novel exons). Thus, TECtool iden-
tifies with high reproducibility many exons not found by transcript
reconstruction methods, with the unique advantage of accurate an-
notation of transcript 3’ ends. TECtool further predicts the coding
region of novel transcripts, thus facilitating downstream analyses of
encoded proteins.
In a recent study Lagarde et al.[184] sequenced samples from four
tissues, in parallel on both short-read and long-read sequencing plat-
forms, and their results allowed us to further validate TECtool-generated
transcript models. Even though full-length RNA Capture Long Seq
(CLS) primarily captures transcripts with high expression (Supple-
mentary Figure B.8), ∼8% of the novel transcripts predicted by TEC-
tool from short-read sequencing were also identified by long-read
sequencing (44, 5, 0, and 1 of the 464, 88, 63, and 20 novel transcripts
predicted from testis, brain, heart, and liver samples, respectively).
Thus, CLS validates highly expressed TECtool-predicted transcripts,
and altogether our analysis shows that TECtool can substantially im-
prove transcriptome annotation.
3.3.4 TECtool identifies cell-type-specific isoforms
Using an RNA-seq dataset that covers 32 human tissues [185], we
identified hundreds of previously unknown terminal exons with TEC-
tool, primarily from testis and bone marrow samples (Figure 3.4 A).
This was not a mere reflection of the size of the libraries (Supplemen-
tary Figure B.9). Furthermore, many previously unknown isoforms
were the most expressed transcripts of their corresponding genes
(Supplementary Figure B.10), which indicates a special relevance of
intronic PASs in these tissues.
3.3.5 Previously unknown isoforms are expressed in subsets of single cells
Single-cell RNA-seq allows one to assess whether a low average ex-
pression of a particular transcript results from ’transcriptional noise’,
affecting all cells, or from highly specific expression in rare cell types.
By applying TECtool to a recently published single cell RNA-seq
dataset of 201 T cells [186], we found that the distribution of expres-
sion levels for novel isoforms in individual cells was in the range of
that of annotated isoforms. Once transcripts reached an average ex-
pression of 1–2 reads per million per cell (considering only reads that
spliced into the 5’ splice site of the terminal exon), we started to de-
tect them in multiple cells (Supplementary Figure B.11 A). However,
multiple isoforms with distinct terminal exons were rarely present in
a cell at the same time (Supplementary Figure B.11 B). Thus, rather
than being coexpressed with the more abundant annotated isoforms,
novel isoforms appeared to be expressed in subsets of cells, at a per-
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Figure 3.3: Evaluation of TECtool’s performance. (A) Scatter plot of esti-
mated expression levels of already annotated transcripts (ENSEMBL v87;
TSL1-5, blue, 168,726 transcripts) and of transcripts ending at TECtool-
identified terminal exons (red; 842 novel transcripts) in biological replicates
of RNA-seq from HEK293 cells (rp indicates the corresponding Pearson cor-
relation). TPM, transcripts per million. (B) Translational efficiencies com-
puted for annotated terminal exons, novel terminal exons, and intronic re-
gions (two-tailed t test P values for pairwise comparisons of regions based
on TSL1-5: novel versus intron replicate 1 (rep1) , 2.1 × 1016; replicate 2
(rep2), 5.4× 1018; annotated versus novel, rep1, 1.4× 10−5; rep2, 8.6× 10−7).
The numbers of annotated and novel exons and of introns were 16,068, 24,
and 64,455 in rep1, and 15,772, 25, and 63,932 in rep2. Boxes indicate the
IQR, with the center line corresponding to the median; whiskers extend to
the most extreme value within 1.5 times the IQR from the hinge, and outliers
beyond this range are shown as individual points. (C) Cumulative distribu-
tion of the length of novel terminal exons identified by TECtool, StringTie,
and Cufflinks in the two replicate RNA-seq datasets, relative to the TSL1-5
annotation. The number of novel terminal exons identified by each tool is
indicated in parentheses. (D) Distance between experimentally determined
PASs from the PolyAsite atlas [94] and the 3’ ends of novel transcripts iden-
tified by StringTie (top) and Cufflinks (bottom). Pie charts show the number
of 3’ ends of novel transcripts that had an experimentally determined PAS
within +/-200 nt (blue), had experimentally determined PASs farther away
but in the same intron (red), or did not have any experimentally observed
PASs in the respective intron (white).
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cell level similar to that of annotated transcripts (Figure 3.4 B and
(Supplementary Figure B.11 C, D). These results illustrate the poten-
tial of TECtool to improve the characterization of transcript isoforms
expressed in individual cells, thereby enabling the characterization of
rare cell types.
3.4 discussion
After the initial assembly of the human genome [2] [1], full-length
RNAs and expressed sequence tags were used to annotate gene struc-
tures [26] [187]. However, many transcripts that are specific to cell
types or conditions remain uncharacterized, even though targeted se-
quencing of RNA 3’ ends hints at their existence [94] [15]. Although
analysis of RNA-seq data increasingly involves transcript reconstruc-
tion, the accuracy of the approach is limited by alignment errors, in-
tron retention events, and 3’ -end bias when poly(A) selection is per-
formed [67] [188]. Terminal exons are especially problematic, as the
transcript coverage by RNA-seq reads decreases toward the 3’ end.
We demonstrated that the accuracy of isoform annotation can be sub-
stantially improved by the incorporation of experimentally identified
PASs in transcript reconstruction. The approach can be applied to any
RNA-seq dataset from a species for which PASs have been mapped,
including human and mouse (Supplementary Figure B.12). Similar
to transcript reconstruction methods, TECtool relies on high-quality
RNA-seq data from samples with minimal RNA degradation and lit-
tle bias in coverage along transcripts. We obtained good results with
samples for which transcript integrity scores [189] were greater than
0.8. TECtool also provides the option to analyze new datasets with
a model build from samples with deep coverage and high RNA in-
tegrity, such as the HEK293 RNA-seq datasets that we used in this
study, which permits analysis of samples with insufficient coverage
and training examples.
Although third-generation sequencing technologies have made the
full-length sequencing of RNAs more common, the capture of low-
abundance transcripts remains very limited. By making use of exten-
sive short-read sequencing data available from cell populations, and
especially from single cells, TECtool supports the identification of
even relatively rare transcripts. The tool is fully automated and easy
to use. It does not require any customized input files or specific pa-
rameters, as it trains its own classifier on the basis of the input data.
3.5 methods
3.5.1 Datasets
Datasets used were downloaded either from http://polyasite.unibas.
ch, or GEO data base [21], or Array Express data base [190]. Table 3.1
summarizes all the datasets.
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Figure 3.4: TECtool identifies previously unknown isoforms with cell-type-
specific expression. (A) Number of previously unknown terminal exons
identified by TECtool in at least one sample from the indicated tissues. (B)
VPS37B gene locus with the ENSEMBL-annotated transcripts (blue), previ-
ously unknown transcripts predicted by TECtool (red), and Sashimi [115]
plots of RNA-seq read densities (gray) from two single T cells (labeled as
cells K and L, respectively).
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Table 3.1: Datasets used for TECtool analysis
Dataset Dataset reference Downloaded from
3’ end sequencing [94] (http://polyasite.unibas.ch)
RNA-seq in HEK 293 [181] GEO database [21]: GSE56010
Ribosome profiling in HEK 293 [182] GEO database [21]: GSE73136
RNA-seq in tissues from Protein Atlas [185] ArrayExpress database [190]: E-MTAB-2836
RNA-seq and PacBio reads in 4 different tissues [184] GEO database [21]: GSE93848
Single-cell data [186] GEO database [21]: GSE85527
Mouse data [191] GEO database [21]: GSE52260
3.5.2 Poly(A) sites
The genome coordinates of the poly(A) sites from the recently pub-
lished atlas [94] were converted to the GRCh38 genome assembly ver-
sion with liftOver [192].
3.5.3 Analysis of intronic poly(A) sites identified by 3’-end processing
The locations of all poly(A) sites were associated with the set of tran-
scripts of support levels 1-5 from the ENSEMBL gene annotation ver-
sion 87 [187]. Pre-mRNA cleavage sites inferred from the samples that
were part of two 3’ end sequencing studies, utilizing either the 3’-Seq
[180] or the SAPAS [193] protocol, were intersected with the anno-
tated PAS and sets of PAS expressed at the level of at least five reads
per million in individual samples were identified. PAS from introns,
terminal exons or terminal exons with downstream stop codon in the
same gene were identified in the basis of the ENSEMBL annotation.
3.5.4 TECtool
TECtool is implemented as open source Python (version 3.4 and higher)
software that can be obtained from http://tectool.unibas.ch. It
depends on the packages HTSeq [55] (version 0.9.1), Bedtools [57]
(version 2.26.0 ), Pybedtools [194] (version 0.7.10), pyfasta (version
0.5.2), numpy [195] (version 1.13), scipy [196] (version 0.19), scikit-
learn [197] (version 0.19.0), pandas [198] (version 0.2) and progress
(version 1.3).
3.5.4.1 Inputs, outputs and user options
TECtool requires the following inputs (Figure 3.2 B): (1) a file contain-
ing all chromosomes in fasta format, (2) a file with the corresponding
annotation in ENSEMBL GTF format [187], (3) a file with genome
coordinates of 3’ end processing sites (in BED format) and (4) a file
containing spliced alignments of RNA-seq reads to the correspond-
ing genome (in BAM format, sorted by coordinates and indexed). For
human and mouse, downloadable files of poly(A) sites can be found
on the website of the PolyAsite atlas http://polyasite.unibas.ch,
[94]). The output of TECtool (Figure 3.2 B) is an augmented annota-
tion file (in GTF format), that contains the input as well as the newly
annotated transcripts. Additional files, summarizing the features of
58
annotated and newly identified exons, that are generated during the
run, are also provided (in tab-delimited format). The tool requires
that the sequencing direction be specified (as forward/unstranded)
for the reads in the BAM file using the –sequencing_direction flag.
Other implemented options allow the specification of the number of
spliced reads required to support a novel exon, or whether to en-
force the use of specific features in training the model and predicting
new terminal exons. The tool can also be run with a user-specified,
pre-trained model (TECtool options: –use_precalculated_training_set,
–training_set_directory) that the user would need to obtain in a pre-
liminary run with a dataset with good transcript coverage by reads.
This may be useful when the coverage of annotated exons in the in-
put RNA-seq data is low and therefore too few data are available to
train an appropriate model.
3.5.4.2 Selection of intronic PASs
In a first step, TECtool uses the provided transcript and PAS anno-
tations of the genome to select candidate intronic PASs. These are
located within the loci of annotated genes, but outside of annotated
exons. When the RNA-seq data used did not preserve strand infor-
mation, TECtool discards PASs that are located in introns of genes
that have other exons annotated on the complementary strand.
3.5.4.3 Identification of candidate novel terminal exon
For each intronic PAS, TECtool defines a ’feature’ region that extends
from the PAS to the closest upstream exon (Figure 3.2 C). The up-
stream exon is considered the ’reference’ region. When the upstream
exon has multiple possible 5’ ends, the longest exon variant becomes
the ’reference’ region.
Uniquely mapping reads overlapping the feature region, either un-
spliced or mapping across splice junctions, with the 5’ end in an exon
upstream of the candidate intronic PAS and the 3’ splice site within
the feature region, are identified. When the number of such spliced
reads surpasses a user-defined lower bound (default: five reads), a pu-
tative terminal exon is constructed extending from the 5’ splice site
of the spliced reads to the intronic PAS. Potential terminal exons that
overlap with annotated exons of other genes are not considered.
3.5.4.4 Collection of training exonic regions
TECtool aims to classify the following:
1. Terminal exons: unique last exons of annotated transcripts, as
defined in the provided annotation file, not including exons that
overlap with other exons or that do not have the (user-)defined
minimum number of splice-in reads (default: five reads).
2. Internal exons: exons that are neither the first nor the last exon
of an annotated transcript, do not overlap with any other exon,
and have the (user-)defined minimum number of splice-in reads.
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3. ’Background’ regions: annotated terminal exons that do not over-
lap with other exons but have less than the (user-)defined mini-
mum number of splice-in reads.
3.5.4.5 Feature computation
For each exonic region in the training set (object), TECtool computes
the following features Supplementary Figure B.3 B-H:
• Splicing-in-boundary/all: counts of reads that splice from an
upstream region into the 5’ boundary/anywhere within the en-
tire length of the object.
• Splicing-out-boundary/all: counts of reads that splice from the
3’ boundary/anywhere within the entire length of the object to
a downstream region.
• Crossing-in/out-boundary: counts of unspliced reads overlap-
ping the 5’/3’ boundary of the object.
• Unspliced-within-boundaries: counts of unspliced reads that are
contained in the object.
• Reads-within-gene-loci: number of reads that map within gene
loci.
• Union-exon-length: length of the union exons of the gene.
TECtool then calculates (Supplementary Figure B.5):
• Reads-out versus reads-in ratio: the ratio of reads splicing out
or crossing the 3’ boundary of the object and reads splicing in
or crossing the 5’ boundary of the object.
• Normalized region expression: ratio between the expression of
the object (per kilobase, including splicing-in/out-all, crossing-
in/out-boundary, and unspliced-within-boundary reads) and
the expression of the corresponding gene (per kilobase, reads-
within-gene-loci divided by length of union-exons).
• Object length.
• Entropy efficiency: a measure of the ’uniformity’ of read cov-
erage along the object, defined as the Shannon entropy of read
coverage per position divided by the maximum value it can take
based on the object length,
EE(x) = −
∑n
i=1 p(xi)log(p(xi))
log(n)
(3.1)
where n represents the length of the object and p(xi) is the cov-
erage at position i divided by the total coverage along the object,
p(xi) =
xi∑n
j=1 xj
(3.2)
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EE(x) takes values between 0 and 1.
• Relative positions of 5% and 95% quantile coverage: where the
cumulative distribution of read coverage along the object reaches
5% and 95%.
• Splicing-in-all versus 5’ end expression: ratio between the num-
ber of reads splicing into the object (see "Splicing-in-all" above)
and the mean coverage per position over the first 10 nt of the
object.
• Splicing-out-all versus 3’ end expression: ratio between the num-
ber of reads splicing out from the object (see "Splicing-out-all"
above) and the mean coverage per position over the last 10 nt of
the object.
• Crossing-in versus 5’ end expression: ratio between the num-
ber of reads overlapping the 5’ boundary of the object (see
"Crossing-in-boundary" above) and the mean coverage per po-
sition over the first 10 nt of the object.
• Crossing-out versus 3’ end expression: ratio between the num-
ber of reads overlapping the 3’ boundary of the object (see
"Crossing-out-boundary" above) and the mean coverage per po-
sition over the last 10 nt of the object.
• Splicing-in-boundary versus 5’ end expression: ratio between
the number of reads splicing into the object (see "Splicing-in-
boundary" above) and the mean coverage per position over the
first 10 nt of the region.
• Splicing-out-boundary versus 3’ end expression: ratio between
the number of reads splicing out from the object (see "Splicing-
out-boundary" above) and the mean coverage per position over
the last 10 nt of the region.
• Splicing-in-boundary versus Splicing-in-all: ratio between the
number of reads splicing into the 5’ boundary of the object (see
"Splicing-in-boundary" above) and the number of reads splicing
into the object (see "Splicing-in-all" above).
3.5.5 Classifier training and prediction of novel terminal exons
TECtool samples randomly 20% of the training data for validation,
and approximates the distributions of all features described above
for each region type in the remaining 80% of the training data (Sup-
plementary Figure B.4 A) using kernel density estimation (KDE). We
chose an exponential kernel function to better approximate drops at
the boundary of the empirical distributions. Under the assumption
of uncorrelated features, the KDEs represent posterior probabilities
to use in the Bayes classifier. As samples generated with different se-
quencing protocols typically have different coverage patterns along
genes, the features that best distinguish exon types may change from
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sample to sample. Thus, TECtool uses a forward greedy feature se-
lection, incrementally and greedily adding features that increase the
performance (F1-score t value > 1.37) on the validation data, starting
from a core set of features (entropy efficiency and reads-out versus
reads-in ratio). To increase the stability of the model, TECtool trains
classifiers on ten randomized subsets of the training data (1,000 ob-
jects in each class, or the entire set if smaller than 1,000), and then
uses each of them to evaluate each candidate terminal exon (Supple-
mentary Figure B.4 A). The average probabilities that the candidate
exon will be terminal, internal, or background, computed over the
ten classifiers, determine the category to which the candidate exon is
assigned. When there are multiple putative terminal exons with the
same 5’ splice site but different PASs, only the exon with the highest
probability of being terminal is reported in the final GTF.
3.5.6 Novel transcripts and CDS annotation
Having identified putative terminal exons, TECtool constructs puta-
tive novel transcripts, starting from annotated transcripts that con-
tain an exon that splices to the novel terminal exon. These transcripts
(which we call root transcripts) and upstream exons are identified on
the basis of spliced reads.
In the final step, TECtool annotates the putative protein-coding re-
gion in the newly annotated transcripts. When the root transcript is
protein coding, TECtool uses the already annotated start codon and
searches for the first in-frame stop codon. If it is found, the novel tran-
script is annotated as protein coding. When the root transcript has no
annotated start codon or when no in-frame stop codon is found, the
transcript is classified as noncoding.
3.5.7 Automated analysis of RNA-seq datasets with TECtool
We implemented automated TECtool analyses of standard RNA-seq
(Supplementary Figure B.3 A), as well as single-cell RNA-seq data
(Supplementary Figure B.6). The analysis flows are implemented in
the snakemake framework [30], and the parameters for each type
of analysis are specified in a corresponding configuration file. The
single-cell sequencing data pose the challenge of relative low and
highly nonuniform coverage for most genes. Therefore, we initially
pool the data from all cells in a sample to identify the terminal ex-
ons, which we then quantify in individual cells with a method for
transcript isoform quantification.
3.5.8 Analysis of mouse RNA-sequencing data
To demonstrate the generality of the tool, we also applied it to RNA-
seq data from a time series of mouse T cell activation (accession
GSE52260). A summary of the results for individual time points is
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shown in Supplementary Figure B.12, together with genome browser
screenshots for two individual examples.
3.5.9 Analysis of novel transcript expression in 32 human tissues
We analyzed the mRNA-seq data generated for 32 human tissues
[185] with TECtool. We merged the enriched annotation files cor-
responding to replicate samples from the same tissue, to construct
tissue-specific annotation files. Estimates of transcript and gene ex-
pression levels in each tissue were obtained with Salmon [199].
3.5.10 Visualization of read densities
Sashimi plots [115] were generated with a custom script that is based
on the following R libraries: Gviz [114], rtracklayer [170] and Ge-
nomicFeatures [171].
3.5.11 Statistics
For comparison of translation efficiency, we used two-tailed t tests,
not treating the two variances as equal. The number of cases and P
values are given in the legend of Figure 3.3.
3.5.11.1 Analysis of single end RNA-seq data
For single-end, bulk RNA-seq (Supplementary Figure B.3 A), TEC-
tool first generates the required directories, optionally trims the 3’
adapters using cutadapt [38] (version 1.13)
cutadapt \
--adapter {3’ adapter} \
--error-rate {error rate} \
--minimum-length {minimum read length} \
--overlap {overlap} \
{input reads} | gzip > {output reads}
and indexes the genome with the STAR software [51] (version 2.5.3a)
STAR \
--runMode genomeGenerate \
--sjdbOverhang {read length} \
--genomeDir {genome dir} \
--genomeFastaFiles {genome fasta file} \
--runThreadN {number of threads} \
--sjdbGTFfile {annotation file}
The reads are mapped to the genome with the STAR aligner
STAR \
--runMode alignReads \
--twopassMode Basic \
--runThreadN {number of threads} \
--genomeDir {genome dir} \
--sjdbGTFfile {annotation file} \
--readFilesIn {sample fastq file} \
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--readFilesCommand zcat \
--outFileNamePrefix {prefix} \
--outSAMtype BAM Unsorted
Alignment files (in BAM format) are then sorted
samtools sort \
-@ {number of threads} \
{input bam} > {output bam}
and indexed
samtools index {input bam}
using samtools [45] (version 1.3). The sorted alignment file and ap-
propriate input options are provided to TECtool
tectool \
--annotation {input annotation file} \
--polyasites {input polya sites} \
--bam {input alignment file} \
--sequencing_direction {sequencing direction option} \
--genome {genome fasta file} \
--minimum_spliced_reads_for_cryptic_exon_start_site 5 \
--output_dir {output directory}
to identify novel terminal exons and output an enriched annotation
file (in gtf format). The gtf files from different replicates are then
merged
tectool_add_novel_transcripts_to_gtf_file \
--list_of_gtf_files {list of gtf files} \
--out-dir {output directory}
into a single gtf file with a custom TECtool script. A file (fasta
format) of transcript sequences is generated based on the annotation
file with the gffread script from the cufflinks package [138] (version
2.2.1)
gffread \
{merged annotation file} \
-g {genome fasta file} \
-w {transcripts fasta file}
Finally, the transcriptome is indexed with Salmon [199] (v0.9.1)
salmon index \
--transcripts {input transcript sequences} \
--index {output index} \
--kmerLen {kmer length} \
--keepDuplicates \
--threads {number of threads}
and the expression levels of transcripts in each replicate are quanti-
fied
salmon quant \
--index {input index} \
--libType {library type} \
--unmatedReads {input reads} \
--seqBias \
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--geneMap {merged annotation file} \
--fldMean {mean fragment length} \
--fldSD {standard deviation of fragment length} \
--useVBOpt \
--threads {number of threads} \
--output {output directory}
We used Salmon for isoform quantification (the successor of Sail-
fish [145]), because we found Sailfish to perform well relative to other
methods for isoform quantification [200]. Similar results for Salmon
were reported by others [201]. Other methods for transcript quan-
tification can also be used. The output of this final step consists of
transcript and gene expression estimates (in TPM).
3.5.11.2 Analysis of paired-end RNA-seq data
For paired-end bulk RNA-seq (Supplementary Figure B.3 A) TECtool
first selects one of the two mates depending on a user-set parameter
and then continues as described above. However, adapter trimming
cutadapt \
-a {3’ adapter mate 1} \
-A {3’ adapter mate 2} \
--error-rate {error rate} \
--minimum-length {minimum read length} \
--overlap {overlap} \
-o {mate 1 output reads} \
-p {mate 2 output reads} \
{mate 1 input reads} {mate 2 input reads}
and the transcript expression estimation
salmon quant \
--index {input index} \
--libType {library type} \
-1 {mate 1 input reads} \
-2 {mate 2 input reads} \
--seqBias \
--geneMap {merged annotation file} \
--useVBOpt \
--threads {number of threads} \
--output {output directory}
is performed in paired-end and not single-end mode.
3.5.11.3 Analysis of single cell sequencing data
Single cell sequencing data (Supplementary Figure B.6) poses the ad-
ditional challenge that the coverage of individual genes is generally
sparse and non-uniform. Thus, after the necessary directories are cre-
ated, the genome is indexed with STAR and 3’ adapters are trimmed
with cutadapt, the read files corresponding to individual cells are con-
catenated, the reads are mapped to the genome with STAR and the
alignment file is sorted and indexed with samtools. PCR duplicates
are removed with samtools
samtools rmdup \
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-s {input alignment file} \
{output alignment file}
and the resulting alignment file is provided as input to TECtool to
identify novel exons and transcripts. Reads from individual cells are
mapped to the genome with STAR and sorted with samtools. PCR
duplicates are also removed from the alignment using samtools and
then indexed. To quantify expression of transcripts that indeed in-
clude specific terminal exons, in spite of the sparse coverage of genes
by reads in individual cells, we estimated the expression of novel and
annotated transcripts as the number of split reads that fall in the 5’
splice junction of the respective exons (novel or annotated terminal
exons that do not overlap with annotated internal exons).
3.5.12 Analysis of TECtool running time
Data from a time series of mouse T cell activation (accession GSE52260)
were merged and mapped to the genome with STAR. After sorting
the alignment file and removal of PCR duplicates with samtools, we
kept only primary alignments
samtools view \
-F 0x100 \
-bS {input alignment file} \
> {output alignment file}
and generated subsets representing 10%, 20%, 30%, 40%, 50%, 60%,
70%, 80%, and 90% of the total number of reads
samtools view \
-s {subset fraction size} \
-b {input alignment file} \
> {output alignment file}
with samtools. We applied TECtool to each of the datasets, using
the bash command time to obtain the running time. We repeated the
procedure 10 times for each data set size to obtain averages and stan-
dard deviations of the running time for each data set size. All samples
were run in a single core with 64GB of memory. The results are shown
in Supplementary Figure B.4 B.
3.5.13 Analysis of ribosome profiling data
For the analysis of translation, we only considered novel terminal ex-
ons containing a stop codon. We mapped ribosome-protected reads
to the genome with STAR and the parameters used for bulk RNA-
seq data. We counted mapped reads with HTSeq [55], constructed
profiles of ribosome footprints around the stop codon and estimate
the density of ribosomes over the terminal exons. Estimates of tran-
script abundance (transcripts per million, TPM) from Salmon [199]
were used to normalize Ribo-seq read densities (expressed in reads
per kilobase per million, RPKM). The profile of ribosome footprints in
intronic regions have been normalized to the expression level of the
most expressed isoform of that gene (TPM), inferred with Salmon.
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3.5.14 Transcript and terminal exon reconstruction with StringTie
StringTie [183] (version 1.3.3) has been found most accurate among
transcript reconstruction methods in a recent benchmarking study
[67]. We mapped RNA-seq reads obtained in a previous study [181]
to the genome in paired end mode with the STAR aligner
STAR \
--runMode alignReads \
--twopassMode Basic \
--runThreadN {number of threads} \
--genomeDir {genome dir} \
--sjdbGTFfile {annotation file} \
--readFilesIn {sample mate 1 fastq file} {sample mate 2 fastq
file} \
--readFilesCommand zcat \
--outFileNamePrefix {prefix} \
--outSAMtype BAM Unsorted \
--outSAMstrandField intronMotif
After sorting and indexing the alignments with samtools, we ran
StringTie with the following command
stringtie \
{input alignment file} \
-G {annotation file} \
-o {output annotation file} \
{library type} \
-p {threads}
to generate gtf files with the new annotation. Finally, we extracted
novel terminal exons that were located in introns relative to the sup-
port level 1-5 transcript annotation of the genome.
3.5.14.1 Transcript and terminal exon reconstruction with Cufflinks
Cufflinks [138] (version 2.2.1) is a second transcript reconstruction
method with relatively good performance in a recent benchmarking
[67]. We used the alignments of reads to genome obtained as de-
scribed for Stringtie, and after sorting and indexing with samtools
we ran Cufflinks with the following options
cufflinks \
--num-threads {number of threads} \
-g {annotation file} \
--library-type {library type} \
-o {output directory} {input alignment file}
obtaining a gtf file with novel and known transcripts for each sam-
ple. From transcripts with at least two exons, we then extracted ter-
minal exons that were located in introns relative to the TSL1-5 anno-
tation, using custom scripts and bedtools.
3.5.15 Parallel analysis of long and short read data
We used cutadapt [38] to trim 5’ and 3’ adapters, polyA and polyT
stretches from PACbio reads, with the following commands:
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cutadapt \
--front {5’ adapter} \
--error-rate {error rate} \
--minimum-length {minimum read length} \
--overlap {overlap} \
{input reads} | gzip > {output reads}
and
cutadapt \
--adapter {3’ adapter} \
--error-rate {error rate} \
--minimum-length {minimum read length} \
--overlap {overlap} \
{input reads} | gzip > {output reads}
We indexed the genome with the STAR [51] software (version 2.5.3a)
STARlong \
--runMode genomeGenerate \
--sjdbOverhang {read length} \
--genomeDir {genome dir} \
--genomeFastaFiles {genome fasta file} \
--runThreadN {number of threads} \
--sjdbGTFfile {annotation file})
and mapped the long, PACbio reads to the genome with the STAR-
long version of the STAR aligner
STARlong \
--runMode alignReads \
--outFilterMultimapScoreRange 20 \
--outFilterScoreMinOverLread 0 \
--outFilterMatchNminOverLread 0.5 \
--outFilterMismatchNmax 1000 \
--winAnchorMultimapNmax 200 \
--seedSearchStartLmax 50 \
--seedPerReadNmax 100000 \
--seedPerWindowNmax 100 \
--alignTranscriptsPerReadNmax 100000 \
--alignTranscriptsPerWindowNmax 10000 \
--genomeSAsparseD 4 \
--outSAMunmapped Within \
--runThreadN {threads} \
--genomeDir {genome dir} \
--sjdbGTFfile {annotation file} \
--readFilesIn {input reads} \
--readFilesCommand zcat \
--outFileNamePrefix {prefix} \
--outSAMtype BAM Unsorted
We sorted
samtools sort \
-@ {number of threads} \
{input bam} > {output bam})
and indexed
samtools index {input bam}
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the alignments with samtools [45]. After trimming the soft clipped
parts of the mapped sequences,
samtools view -h {input alignment file in bam format} \
| awk ’BEGIN { OFS="\t"} { \
split($6,C,/[0-9]*/); \
split($6,L,/[SMDIN]/); \
if (C[2]=="S") {
$10=substr($10,L[1]+1); \
$11=substr($11,L[1]+1); \
}; \
if (C[length(C)]=="S") {
L1=length($10)-L[length(L)-1]; \
$10=substr($10,1,L1); \
$11=substr($11,1,L1); \
}; \
gsub(/[0-9]*S/,"",$6); \
print \
}’ \
| samtools view -bS - > {output alignment file in bam format}
we extracted transcript coordinates from the alignment file with
bedtools [57] (version 2.26.0)
bedtools bamtobed \
-i {alignment file} \
-bed12 \
-splitD > {bed12 coordinates file}
to generate a bed12 file, and the extracted transcript sequences
from the genome
bedtools getfasta \
-split \
-s \
-name \
-fi {genome sequence} \
-bed {transcript coordinates} \
-fo {transcript sequences}
In parallel we generated enriched annotation files by applying TEC-
tool to the short read data also generated for the respective samples.
We then mapped the PACbio-sequenced transcripts to annotated and
novel transcripts with blast [202], first building the index of annotated
and novel transcripts
makeblastdb \
-in {transcript sequences} \
-dbtype nucl \
-out {Blast database name}
and then running BLAST+ [203] (version 2.6.0)
blastn \
-num_threads {threads} \
-db {params.db_prefix} \
-query {PACbio extracted transcripts} \
-outfmt "6 qseqid sseqid pident qlen length slen mismatch gapopen
evalue bitscore" \
-out {blast result}
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From the blast output files we kept only transcripts that did not con-
tain any internal gaps (gapopen=0), for which the alignment length
(length) did not differ by more than 40 nts from either query (qlen)
and target (slen) sequence lengths. This allows only small differences
in the initiation/termination sites, but not incorrect assignment of
splice variants.
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4
D I S C U S S I O N
Hundreds of thousands HTS data sets are available in public repos-
itories such as GEO or SRA, and much more are expected to be se-
quenced and deposited in the near future. Most of them originate
from technologies that generate short reads, such as Illumina [204].
These data are quite heterogeneous, since they were obtained from
a variety of organisms, cell types, experimental protocols and instru-
ments. Nevertheless, they reflect a large community effort in under-
standing biological processes and it would be highly desirable to
make use of these data beyond the initial studies. In the work de-
scribed in this thesis, I aimed to improve the characterization of gene
expression by further exploiting existing high throughput data sets
(mainly RNA-seq and 3’end sequencing). Towards this goal, I have
developed a live tool for studying the performance of methods that
quantify the abundance of transcript isoforms and I have developed
a novel tool to uncover terminal exon isoforms.
In chapter 2 I described our strategy to benchmark programs that
quantify isoform abundance. In contrast to most studies, that use
for this purpose simulated RNA-seq reads, we have also attempted
to quantify equivalence classes of transcripts (those that share the
poly(A) site) by an independent experimental method, namely by
mRNA 3’ end sequencing. We applied this approach to human Jurkat
and murine NIH/3T3 cells, from which we prepared and sequenced
parallel samples by RNA-seq and 3’ end sequencing (A-seq2 proto-
col). We felt that this was important, because RNA sequencing suf-
fers from a variety of biases introduced by the different experimental
steps that are not easy to simulate. We found that most programs
for isoform quantification performed reasonably well, although a few
‘winners’ were apparent. Interestingly, all of these methods were more
accurate in estimating gene level expression (by summing expression
of transcripts associated with the gene) than widely used count-based
approaches that handle poorly isoforms with different lengths. The
main difference between the quantification methods lied not in their
accuracy but rather in the amount of resources that they required
(runtime and memory). This is important, because, as the size of the
data sets continues to increase, only few current methods will con-
tinue to be practically usable. Importantly, we found that the tran-
scripts and isoforms that have relatively low abundance are poorly
quantified by essentially all methods, indicating that this is an area
where substantially more work needs to be invested, computationally,
but also experimentally.
In chapter 3 I described a novel computational tool (TECtool) to
identify transcripts that contain unannotated terminal exons based
on RNA-seq data and poly(A) sites obtained from 3’ end sequenc-
ing experiments. The method is relevant because ¼ of the poly(A)
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sites identified by 3’ end sequencing fall in regions annotated as in-
trons. Transcript reconstruction methods are insufficiently accurate
in detecting these exons, presumably because they have to be very
stringent in separating spurious read coverage from expressed exons.
This is is less of a problem for internal exons, for which reads sup-
porting both the 5’ and 3’ splice sites are expected. In contrast, for
terminal exons, the 3’ end is imprecisely defined and the coverage
immediately upstream of the poly(A) site is typically poor, as very
short fragments from the end of the transcripts are lost during the
size selection step of the experimental protocol. With TECtool we
found many novel tissue-specific transcripts. Tissues like bone mar-
row and testis are enriched in novel transcripts, but their functions
are at the moment poorly understood. The enriched annotation that
we provide opens the possibility to improve the quantification of ex-
pression of these novel transcripts across experimental conditions, to
gain insights into the regulation of their expression and in the pro-
cesses in which they are involved. Ribo-seq data indicate that many
of the newly identified transcripts can be translated. With TECtool we
could also explore the expression of terminal exon isoforms in single
cells. Here we have noticed that transcripts that have low expression
at the population level are not expressed at uniformly low levels in
single cells, but rather they are well expressed in a smaller propor-
tion of cells than transcripts with higher average expression. This is
perhaps not unexpected, as transcription occurs in bursts, and it is
possible that the transcripts of a burst experience a similar process-
ing environment, which leads to their being more similarly processed
than transcripts that expressed from the same gene but at very differ-
ent times or in different cells. This seems an interesting line of further
investigation based on single cell data. Finally, while technologies for
full-length cDNA or RNA sequencing are available, we found that
TECtool can identify more novel transcripts based on short read data,
simply because the throughput of technologies generating long reads
(such as PACBio) is much lower.
With my computer science background, I made specific efforts to
make the tools available to the public and enforce the reproducibil-
ity of the analyses [205]. The code to generate all results and figures
of chapter 2 is publicly available in a repository https://github.com/
zavolanlab/IsoformQuantificationBenchmarking. Additionally, I cre-
ated a supplementary website where developers of new methods
can upload estimates isoform expression generated by their tools
based on the experimental and synthetic data that we made avail-
able, to compare the results with the results from the approaches we
assessed already. Our idea of a live site for benchmarking computa-
tional methods was also adopted by another group, who also used a
subset of the data to provide the community with a shiny application
for comparing binary classification methods [206]. The TECtool and
three additional repositories with pipelines for processing single-end,
paired-end, and single-cell RNA-seq data can also be obtained from
http://tectool.unibas.ch/. and a supplementary website with fur-
ther information and data is also available. One of directions in which
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I am currently working is in automating to a very large extent the pro-
cessing of HTS data. Specifically, I am developing a web server that
will users to upload raw HTS data, process them with the methods
described in these thesis and return publication-ready plots. As data
processing has become an important bottleneck also for molecular
biologists, this type of service could have an important impact on ex-
perimental research. I am especially interested in exploring the use of
these tools in analyzing patient transcriptome data, which will likely
be generated soon in personalized health projects.
I see a lot of potential in developing the TECtool further. Currently,
TECtool processes every sample independently and cannot take ad-
vantage of replicates. In the future, the method can be improved
by incorporating the variability between replicates in the model that
scores putative terminal exons. TECtool is built explicitly for identify-
ing transcripts with novel 3’ terminal exons. However, It is relatively
easy to adapt the method to identify alternative 5’ exons starting from
CAGE/promoter data instead of 3’ end sequencing data/poly(A) sites.
Moreover, the tool can be further expanded to perform not only ex-
on/transcript annotation but also differential expression of the iden-
tified terminal exons or transcripts. Many of the features and tools
developed in these chapters can be used to build new methods to
study splicing or RNA processing in general. For example, one could
apply features used to identify novel terminal exons to improve the
quantification of internal exon usage, which is currently done com-
monly through the percent spliced in score. Furthermore, one can
also attempt to learn about and identify specific exons or events that
current methods are not able to quantify, such as micro-exons or small
variations at the 3’ splice site (so-called NAGNAG splicing). Ideally,
a tool that can identify novel intermediate, start and terminal exons
using RNA-seq, CAGE and 3’ end sequencing data, reconstruct tran-
script forms, quantify their expression and estimate the inclusion of
specific events would be a great aid towards the effort of annotating
and characterizing the transcriptome of different organisms and cells.
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Supplementary Figure A.1: Overview of the study design. Sequencing
data (blue boxes; 1) were generated synthetically (Flux Simulator; left side)
or experimentally (right side) from human or mouse cells, following ei-
ther a regular RNA-seq (blue arrows) or an A-seq-2 3’ end sequencing
protocol (red arrows). 3’ adapters (if present) and poly(A)-tails were re-
moved from read sequences (’pre-processing’), and the trimmed reads were
then aligned against both the genome and the transcriptome (green boxes;
2). Genome alignments were supplemented with read alignments covering
splice junctions by converting transcriptome alignments to genome coordi-
nates. Genome and transcriptome alignments were then compared to ensure
that only the best alignments were kept for each read. Based on the remain-
ing alignments (genome or transcriptome, depending on requirements), ex-
pression estimates were computed (red boxes) either with the surveyed,
model-based methods (3a), or count-based methods (RNA-seq: 3b, A-seq-
2: 3c). Subsequently (’post-processing’), the raw numbers produced by the
latter methods, as well as the true number of expressed transcripts in the
synthetic dataset (as provided by Flux Simulator; gray arrow), were nor-
malized, and the normalized expression estimates were extracted from the
outputs of the surveyed model-based inference methods. Depending on the
downstream analysis, expression estimates for transcripts and 3’ end pro-
cessing sites (’Poly(A)’) were aggregated and filtered (purple boxes; 4). To
evaluate the performance of the surveyed methods (magenta boxes; 5), the
accuracy of the surveyed transcripts abundance inference methods were an-
alyzed by comparing the produced estimates to either the ground truth
expression (synthetic data) or the A-seq-2-based estimates (experimental
data). Additionally, runtime and memory consumption was evaluated. Steps
at which either transcript/gene annotations (GENCODE) or transcript se-
quences (ENSEMBL) were used are marked with white triangles at the up-
per left corners. Refer to the Methods section and the main text for further
details.
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Supplementary Figure A.2: Multithreading efficiency and running time /
memory footprint trade-off. Transcript isoform abundances were estimated
with each of the indicated methods based on in silico-generated sequencing
datasets. (A) The efficiency of multi-core use is indicated in terms of the
speedup factor (ratio of running times when using 1 compared to 16 cores)
for different sequencing depths. (B and C) Relationships between running
time and memory footprint when processing 100 million reads with either
1 (B) or 16 (C) cores. Note that data for TIGAR2 are unavailable for (A) and
(C), because the method does not support the use of multiple cores.
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Supplementary Figure A.3: Accuracy of transcript isoform abundance esti-
mates inferred from in silico-generated sequencing data. For each method,
correlations between true and inferred transcript abundances are shown as
heat density plots. The corresponding Spearman correlation coefficients (rs)
are indicated. Estimates were produced based on the 30 million read dataset.
(A) BitSeq. (B) CEM. (C) Cufflinks. (D) eXpress. (E) IsoEM. (F) MMSEQ. (G)
RSEM. (H) rSeq. (I) Sailfish. (J) Scripture. (K) TIGAR2.
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Supplementary Figure A.4: Comparison of different metrics for quanti-
fying the accuracy of isoform abundance estimates. The accuracy of ex-
pression level estimates with respect to the ground truth was assessed by
the Spearman and Pearson correlation coefficients, as well as the root mean
square error (RMSE). The values obtained for expressed transcripts (A) and
expressed genes (B) are plotted. Color intensities have been computed per
column by scaling raw values such that the best value (high for correlation
coefficients, low for RMSE) corresponds to the most intense and the worst
to the least intense color.
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Supplementary Figure A.5: Accuracy of gene expression estimates in-
ferred from in silico-generated sequencing data. As in Supplementary Fig-
ure A.3, but estimates were produced for genes instead of transcripts. (A)
BitSeq. (B) CEM. (C) Cufflinks. (D) eXpress. (E) IsoEM. (F) MMSEQ. (G)
RSEM. (H) rSeq. (I) Sailfish. (J) Scripture. (K) TIGAR2. (L) Counting method
’transcript’. (M) Counting method ‘union exon’.
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Supplementary Figure A.6: Accuracy of ’present calls’. The ability of each
method to accurately determine whether a given transcript or gene is ex-
pressed was determined by calculating false positive (A and B) and true
positive (C through F) rates across different sequencing depths. A transcript
(A, C, and E) or gene (B, D, and F) was considered expressed, if it has - ac-
cording to the ground truth - a non-zero expression. In contrast to A through
D, where all features are considered, panels E and F show the true positive
rates only for lowly expressed transcripts and genes (log2 TPM <0 and <1.1,
respectively; compare expression bins in Figure 2.2). Note that by default,
BitSeq and MMSEQ report small non-zero ‘priors’. For these methods, we
included modified estimates (‘priors’ to 0), in which a portion of these small
values were set to zero according to simple algorithms (refer to the main
text and the Methods section for details).
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Supplementary Figure A.7: Accuracy of expression estimates across all
transcripts and genes. As in Figure 2.2 A and B, but including, respectively,
transcripts (A) and genes (B) that are not expressed according to the ground
truth.
(A) (B)
(C) (D)
Supplementary Figure A.8: Effect of ’native’ short-read aligners. For meth-
ods strongly recommending the use of a specific short-read aligner (CEM,
Cufflinks, MMSEQ, Scripture) or using such an aligner internally by default
(RSEM), expression levels inferred based on alignments obtained with the
respective aligners were compared to the estimates produced following our
own processing and alignment pipeline. Accuracies were calculated across
different read depths as in Figure 2.2, either for expressed transcripts (A) or
genes (B), or for all transcripts (C) or genes (D).
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Supplementary Figure A.9: Impact of bias correction settings on simu-
lated data. For methods where an optional sequencing/positional bias cor-
rection setting is implemented, we have compared estimation accuracies ob-
tained when executing the programs with the respective options set or unset.
Accuracies were calculated for 30 million reads as in Figure 2.2, either for
transcripts (A) or genes (B). Default settings (that were also used through-
out this study if not indicated otherwise) are indicated in parentheses after
the method name (circle: bias correction off, triangle: bias correction on).
Note that Cufflinks also has a bias correction option (–frag-bias-correct; de-
fault: off). However, in our hands the program crashed when this option
was specified.
(A) (B)
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Supplementary Figure A.10: Expression level distributions across bins of
transcripts and genes. All transcripts or genes expressed at levels of 0 <
log2 TPM <5.5 were distributed across bins according to transcript length
(A), GC content (B), the number exons per transcript (C), and the number
of transcripts per gene (D). Ranges of the corresponding values covered by
each bin are indicated in the legends to each chart, together with the num-
ber of features (transcripts or genes) they contain. The expression level dis-
tributions of the features in each bin are depicted as cumulative distribution
functions.
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Supplementary Figure A.11: Cufflinks-based abundance estimates of
single-exon transcripts. Cufflinks was used to infer transcript isoform
expression levels from the alignments of 30 million in silico-generated
reads. Alignments were produced either following our own segemehl-based
pipeline (A to C) or by TopHat (D to F). Estimated abundances are plotted
against true abundances for transcripts expressed at 0 < log2 TPM <5.5 and
comprising either one exon (A and D), two exons (B and E), or 11 or more
exons (C and F). Heat map colors reflect the densities of data points and the
corresponding Spearman correlation coefficients (rs) are indicated. For all
single-exon transcripts expressed at 0 < log2 TPM <5.5, transcript isoform
abundances as estimated by Cufflinks are plotted against true abundances.
Supplementary Figure A.12: Impact of gene structural features on expres-
sion estimates. Transcripts and genes have been distributed over different
bins according to the indicated structural features (see Figure 2.3 and main
text). The variation between estimation accuracies for these bins are indi-
cated in terms of the standard deviations σ of the Spearman correlation
coefficients between ground truth and estimates.
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Supplementary Figure A.13: Agreement between expression level esti-
mates for replicates of NIH/3T3 cells. Transcript isoform and gene abun-
dances were estimated with each of the indicated methods based on RNA-
seq data obtained from two biological replicates of murine NIH/3T3 cells.
(A) The agreement between expression estimates for the two replicates are
indicated as Spearman correlation coefficients rs, both at the level of tran-
scripts and genes. (B) A-seq-2-based 3’ end processing site expression level
estimates for the two replicates are plotted against each other. The Spearman
correlation coefficient rs is indicated. (C) As in (B), but estimates are com-
pared at the level of gene expression. (D) As in (A), but with the addition of
3’ end processing site abundances. For computing expression estimates for
either feature type (transcript, 3’ end processing site, and gene), only those
transcripts are considered that end in annotated 3’ end processing sites (see
main text and Methods for details).
(A) (B)
Supplementary Figure A.14: Replicate agreement between abundance es-
timates for features corresponding to expressed 3’ end processing sites.
As in Figure 2.4 D and Supplementary Figure A.13 D, but with the further
requirement that the considered transcripts need to end in annotated 3’ end
processing sites that show evidence of expression, according to the A-seq-2
analysis. Results are shown for replicates of (A) human Jurkat cells and (B)
murine NIH/3T3 cells.
85
rs = 0.856 rs = 0.794 rs = 0.772
rs = 0.796rs = 0.834rs = 0.829
rs = 0.829 rs = 0.823 rs = 0.826
rs = 0.830 rs = 0.817
CEM Cuﬄ inks
eXpress IsoEM MMSEQ
RSEM rSeq Sailﬁsh
Scripture TIGAR2
BitSeq
(A) (B) (C)
(D) (E) (F)
(G) (H) (I)
(J) (K)
Supplementary Figure A.15: Accuracy of 3’ end processing site abundance
estimates inferred from Jurkat sequencing data. Transcript abundances in-
ferred by the surveyed methods from RNA-seq libraries prepared from hu-
man Jurkat cells (replicate 1) were aggregated by 3’ end processing sites and
plotted against the corresponding estimates obtained by the analysis of A-
seq-2 sequencing data. Heat map colors represent data point densities and
Spearman correlation coefficients (rs) are indicated. (A) BitSeq. (B) CEM.
(C) Cufflinks. (D) eXpress. (E) IsoEM. (F) MMSEQ. (G) RSEM. (H) rSeq. (I)
Sailfish. (J) Scripture. (K) TIGAR2.
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Supplementary Figure A.16: Accuracy of 3’ end processing site abundance
estimates inferred from NIH/3T3 sequencing data. As in Supplementary
Figure A.15, but data were from murine NIH/3T3 cells.
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Supplementary Figure A.17: Impact of bias correction settings on abun-
dance estimates from experimental data. As in Supplementary Figure A.9,
but expression estimates were obtained for human (A and B) or mouse (C
and D) cells and also include estimation accuracies on the level of 3’ end pro-
cessing sites. Spearman correlation coefficients were calculated by compari-
son to A-seq-2 estimates (see Figure 2.5) rather than the simulation ground
truth. (A) Jurkat data, replicate 1. (B) Jurkat data, replicate 2. (C) NIH/3T3
data, replicate 1. (D) NIH/3T3 data, replicate 2.
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Supplementary Figure B.1: ’Intronic’ poly(A) sites are processed in a
tissue-specific manner. (A) Top panel: Percentage of ’intronic’ PAS in in-
dividual samples in the data sets obtained with the SAPAS protocol [193].
Bottom panel: corresponding sequencing depths. (B) Position-dependent
frequency of the canonical poly(A) signal (’AAUAAA’) upstream of the
’intronic’ poly(A) sites (orange) and of poly(A) sites corresponding to an-
notated terminal exons (blue) from the study introduced in (A). The usual
position of the poly(A) signal at 21 nts upstream of the cleavage site is indi-
cated by the dashed, vertical line. (C) Distribution of the number of distinct
samples (from panel B) in which individual PAS were observed, for different
types of PAS; ’introns’ - PAS from genomic regions currently annotated as
intronic; ’terminal exon (ds stop)’ - PAS from annotated terminal exons that
are located upstream of an annotated stop codon in the corresponding gene;
’terminal exon’ - PAS from terminal exons with no stop codon annotated
downstream.
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Supplementary Figure B.2: Sashimi plots of gene structures inferred from
the RNA-seq data from different tissues. (A) The Coiled-coil Domain Con-
taining 173 (CCDC173) gene locus with the annotated ENSEMBL transcript
(orange), PAS from the PolyAsite atlas (red lines), and densities of mRNA
reads (gray) from fallopian tube and testis samples. Gray arcs indicate
spliced reads with their corresponding numbers. The novel terminal exon
(red dotted box) is expressed in the fallopian tube, but not in testis, indicat-
ing a sex-dependent isoform switch. Note: Same as Figure 3.2A, but show-
ing all spliced reads. (B) Same representation for part of the Kinesin Family
Member 1B (KIF1B) gene locus. The novel terminal exon (red dotted box)
is mainly expressed in bone marrow. (C) Similar for the locus of lincRNA
LINC01744.
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Supplementary Figure B.3: TECtool analysis for bulk single-end or paired-
end RNA-seq reads. (A) Graphic representation of the analysis flow for
two replicates. (B-H) Features calculated by TECtool for annotated and pu-
tative terminal exons. The region from which these statistics are calculated
is referred to as ’object’. (B) Splicing-in-boundary: Reads that splice from
an upstream region to the 5’ boundary of the object. (C) Splicing-in-all:
Reads that splice from an upstream region anywhere within the object. (D)
Splicing-out-boundary: Reads that splice from the 3’ boundary of the object
to a downstream region. (E) Splicing-out-all: Reads that splice out from any-
where within the object to a downstream region. (F) Crossing-in-boundary:
Unspliced reads that overlap the 5’ boundary of the object. (G) Crossing-
out-boundary: Unspliced reads that overlap the 3’ boundary of the object.
(H) Unspliced-within-boundaries: Unspliced reads that are contained in
the object.
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Supplementary Figure B.4: Overview of the region classification model in
TECtool. (A) Flow chart of the machine learning algorithm in TECtool. (B)
Analysis of TECtool running time. A data set of approximately 123 million
reads was subsampled in increments of 10% (starting from approximately
12 million reads) and analyzed running TECtool on a single CPU. The anal-
ysis was repeated 10 times for each data set size. Shown are the mean and
standard deviation over the 10 runs for each data set size.
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Supplementary Figure B.5: Features used in the model. Schematic repre-
sentation of the features that are used to construct the model and then clas-
sify regions into terminal exons, intermediate exons or background regions.
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Supplementary Figure B.6: TECtool analysis flow for single cell data. Ex-
ample of TECtool analysis of two individual cells.
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Supplementary Figure B.7: Evaluation of TECtool performance. (A) Scat-
ter plot of estimated expression levels of already annotated transcripts (EN-
SEMBL v87, transcript support level 1 (TSL1), blue, 41,676 transcripts) and
of transcripts ending at TECtool-identified terminal exons (red, 893 tran-
scripts), in biological replicates of RNA-seq from HEK 293 cells (rP indicate
the corresponding Pearson correlations). (B) Translational efficiencies com-
puted for annotated terminal exons, novel terminal exons and intronic re-
gions (two-tailed t-test p-values for pairwise comparisons of regions based
on TSL1, novel versus intron replicate 1 (rep1): 5.6e-85; replicate 2 (rep2):
2.3e-84, and annotated versus novel rep1: 1.7e-20; rep2: 2.2e-20). Boxes indi-
cate the interquartile range (IQR) with the line corresponding to the median,
whiskers correspond to the most extreme value that is within 1.5 times the
IQR from the hinge and outliers beyond this range are shown as individual
points. (C) Normalized position-dependent frequencies of ribosome foot-
prints around STOP codons of annotated (upper panel TSL1, lower panel
TSL1-5) or novel transcripts. (D) Smoothened (+/- 5 nucleotides) frequency
profiles of the canonical poly(A) signal (’AAUAAA’) around 3’ ends of tran-
scripts predicted as novel relative to TSL1-5 by TECtool, StringTie and Cuf-
flinks, respectively. (E) Venn diagrams showing the number of unique ter-
minal exons defined only by their 5’ ends, that were predicted by Cufflinks,
StringTie and TECtool from the two replicate HEK 293 RNA-seq data sets us-
ing TSL1-5 annotation. The three-circle Venn diagram shows the relationship
between 5’ end-defined terminal exons that were predicted in both replicates
by the above mentioned tools. (F) Venn diagrams reflecting the reproducibil-
ity of terminal exon prediction by TECtool, StringTie and Cufflinks (using
again ENSEMBL v87 TSL1-5 annotation). Two independent biological repli-
cates were analyzed with the mentioned tools to identify novel terminal ex-
ons. The overlap was then determined when exons were uniquely defined
based on both their 5’ and 3’ genome coordinate, or based only on the 5’
end, or only on the 3’ end.
96
-20 -10 0 5 15
0.
00
0.
04
0.
08
0.
12 Brain
log2 expression
PACbio transcripts (978)
all transcripts (139826)
transcripts with novel terminal exons (88)
(A)
-20 -10 0 5 15
0.
00
0.
04
0.
08
0.
12 Heart
log2 expression
pr
ob
ab
ilit
y d
en
sit
y
PACbio transcripts (959)
all transcripts (128134)
transcripts with novel terminal exons (63)
(B)
-20 -10 0 5 15
0.
00
0.
04
0.
08
0.
12 Liver
log2 expression
pr
ob
ab
ilit
y d
en
sit
y
PACbio transcripts (738)
all transcripts (113127)
transcripts with novel terminal exons (20)
(C)
-20 -10 0 5 15
0.
00
0.
04
0.
08
0.
12 Testis
log2 expression
pr
ob
ab
ilit
y d
en
sit
y
PACbio transcripts (1870)
all transcripts (149779)
transcripts with novel terminal exons (464)
(D)
pr
ob
ab
ilit
y d
en
sit
y
Supplementary Figure B.8: Distribution of expression levels inferred by
Salmon [199] from short read sequencing data. RNA-seq was carried out
from (A) brain, (B) heart, (C) liver and (D) testis samples, and distributions
are shown for various transcript sets: all annotated transcripts (green), tran-
scripts sequenced on the PacBio platform from the corresponding samples
(red), and transcripts with novel terminal exons predicted by TECtool (blue).
The number of transcripts is indicated in parentheses.
97
N
um
be
r o
f n
ov
el
 e
xo
ns
Library size
1e7 2e7 3e7 4e7 5e7
salivary gland
lung
liver
heart
lymph node
prostate
adipose tissue
bone marrow
bladder
adrenal gland
placenta
thyroid
spleen
skin
small intestine
appendix
gallbladder
colon
testis
esophagus
endometrium
stomach
ovary
kidney
pancreas
cerebral cortex
duodenum
fallopian tube
smooth muscle
rectum
skeletal muscle
tonsil
0
50
100
150
(A)
1e7
2e7
3e7
4e7
5e7
0
Av
er
ag
e 
lib
ra
ry
 s
iz
e
(C)
sa
liv
ar
y 
gl
an
d
lu
ng
liv
er
he
ar
t
ly
m
ph
 n
od
e
pr
os
ta
te
ad
ip
os
e 
tis
su
e
bo
ne
 m
ar
ro
w
bl
ad
de
r
ad
re
na
l g
la
nd
pl
ac
en
ta
th
yr
oi
d
sp
le
en sk
in
sm
al
l i
nt
es
tin
e
ap
pe
nd
ix
ga
llb
la
dd
er
co
lo
n
te
st
is
es
op
ha
gu
s
en
do
m
et
riu
m
st
om
ac
h
ov
ar
y
ki
dn
ey
pa
nc
re
as
ce
re
br
al
 c
or
te
x
du
od
en
um
fa
llo
pi
an
 tu
be
sm
oo
th
 m
us
cl
e
re
ct
um
sk
el
et
al
 m
us
cl
e
to
ns
il
Tissues
Av
er
ag
e 
nu
m
be
r o
f n
ov
el
 e
xo
ns
(B)
0
20
40
60
80
100
120
140
Supplementary Figure B.9: Summary of RNA-seq samples from the pro-
tein atlas data set. (A) Scatter plot of the number of mapped reads (mate
1) and number of novel exons identified by TECtool. Pearson’s r = 0.56, p-
value = 3.93e-17. Spearman’s r = 0.73, p-value = 6.44e-34. (B) Barplots of
the number of novel exons identified from individual tissues (black: error
bars indicating standard deviation computed based on replicate samples)
(C) and corresponding library sizes (black: error bars indicating standard
deviation computed based on replicate samples). Note for (A-C): Number
of samples used for each tissue indicated in parenthesis: salivary gland (6),
lung (8), liver (5), heart (9), lymph node (13), prostate (7), adipose tissue
(6), bone marrow (8), bladder (4), adrenal gland (6), placenta (7), thyroid (9),
spleen (5), skin (6), small intestine (8), appendix (6), gallbladder (6), colon
(8), testis (8), esophagus (6), endometrium (6), stomach (4), ovary (5), kid-
ney (4), pancreas (4), cerebral cortex (3), duodenum (4), fallopian tube (6),
smooth muscle (3), rectum (4), skeletal muscle (6), tonsil (3).
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Supplementary Figure B.10: Update update update: Expression of TEC-
tool identified transcripts across 32 human tissues. (A) Distribution of
the mean gene expression contribution of the, on average, most highly ex-
pressed annotated (blue) or novel (red) isoform to the total expression of the
corresponding gene in the indicated tissue. (B) Number of genes for which
a novel transcript is, on average, the dominant expressed isoform. For (A)
and (B) only novel transcripts having a median expression >1 TPM within
a specific tissue were considered.
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Supplementary Figure B.11: TECtool identifies novel isoforms that are
expressed in subsets of single cells. (A) Fractions of cells expressing an-
notated (blue density) or novel (red dots) transcripts, as a function of the
average expression of these transcripts across all cells. (B) Histograms of
the number of transcripts which contribute a specific fraction of expres-
sion of their corresponding gene. Novel transcripts are shown in red, an-
notated transcripts in blue. We subsampled 20 times the set of annotated
transcripts with a mean expression across cells similar to that of novel tran-
scripts (subset size equal to the size of the novel transcripts set), and com-
puted means and standard deviations over the 20 resamplings. Only reads
that spliced into terminal exons were used to estimate the expression of
transcripts containing the respective terminal exons. Furthermore, we only
considered cases where there were at least two distinct reads that could be
counted towards the expression of a given gene. (C) Sashimi plot of the lo-
cus of the O-glucosyltransferase 1 (POGLUT1) gene with the annotated EN-
SEMBL transcripts (blue), the novel transcripts predicted by TECtool (red),
and RNA-seq read densities (gray) within two different cells. Gray arcs in-
dicate spliced reads with their corresponding numbers. The first track indi-
cates that a novel transcript is expressed in cell X, whereas the second track
indicates that another cell, Y, expresses the annotated transcript. (D) Similar
to (C) but for the Pre-mRNA Processing Factor (BCAS2) gene locus.
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Supplementary Figure B.12: TECtool analysis of an RNA-seq data set ob-
tained from mouse CD4+ T cells. (A) Overlap of novel terminal exons
sets identified by TECtool from 3 replicate samples for each of the follow-
ing CD4+ populations: untreated, and the at different time points follow-
ing activation: 0.5, 1, 2, 4, 6, 12, 24, 48 and 72 hours. From replicate 2 of
CD4+ cells 48 hours following activation, no novel terminal exons were
identified. (B) Sashimi plots of gene structures inferred from the mouse
CD4+ cell sequencing data. Part of the Intersectin 2 (Itsn2) gene locus with
the annotated ENSEMBL transcript (orange), PAS from the PolyAsite at-
las (http://www.polyasite.unibas.ch, red tick marks on the track under
the gene structure), and densities of mRNA reads (gray) from 3 replicates
of CD4+ T cells, 72 hours after activation. Gray arcs indicate spliced reads
with their corresponding numbers. Red dotted box shows the novel terminal
exon. (C) Same representation as in (B) but for the Cytidine monophospho-
N-acetylneuraminic acid hydroxylase (Cmah) gene locus.
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This PhD thesis is based on the following publications:
1. Comparative assessment of methods for the computational in-
ference of transcript isoform abundance from RNA-seq data
Alexander Kanitz*, Foivos Gypas*, Andreas J. Gruber, Andreas
R. Gruber, Georges Martin and Mihaela Zavolan. Genome Biol-
ogy. (2015) [200]
* equal contribution
2. Terminal exon characterization with TECtool reveals an abun-
dance of cell-specific isoforms
Andreas J. Gruber*, Foivos Gypas*, Andrea Riba, Ralf Schmidt,
and Mihaela Zavolan. Nat. Methods. (2018) [207]
* equal contribution
Both of the my projects were relatively large, and were developed
together with colleagues from the group of Mihaela Zavolan. In both
cases I was one of the two main authors, which is reflected in the
shared first authorship. In the project described in chapter 2, I con-
tributed to the design of the study, I generated the synthetic datasets,
I communicated with the developers, I installed and executed some
of the surveyed programs, analyzed resulting data, and I wrote sec-
tions of the manuscript. For the project described in chapter 3, I con-
tributed to the design of the study, I co-developed the method, I pack-
aged the tool, I automated the analysis flow, and carried out analyses
to validate the method and demonstrate its performance. I further
contributed to writing the manuscript.
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